data_1q3m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1q3m _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 CA--C 1.531 0.327 0 CA-C-O 120.935 0.306 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -116.01 -30.71 5.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.856 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.655 0.264 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.539 ' HB2' ' HD2' ' A' ' 42' ' ' TYR . 41.8 t . . . . . 0 N--CA 1.464 0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.63 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.382 0.134 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -79.05 118.49 72.77 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 111.187 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 33.1 Cg_exo -60.86 -18.68 58.12 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.028 2.485 . . . . 0.0 113.44 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -47.22 -62.28 1.49 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.494 0.188 . . . . 0.0 111.41 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.8 p -98.29 -14.74 20.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.689 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.531 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 38.9 t70 -59.42 -32.2 69.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.598 0.237 . . . . 0.0 110.808 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.86 -22.9 62.91 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.483 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 41' ' ' ALA . 30.4 tp -56.17 -44.98 79.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.157 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -59.75 -19.18 48.63 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.56 -40.77 89.17 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.539 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -114.48 -19.74 11.05 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.539 HG12 ' CD2' ' A' ' 35' ' ' HIS . 19.6 pt -146.45 -55.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 118.437 0.562 . . . . 0.0 112.473 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.533 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 62.02 72.34 0.66 Allowed Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.176 -0.535 . . . . 0.0 113.254 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -120.0 -73.0 0.66 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.673 0.236 . . . . 0.0 111.613 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -179.6 -31.47 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 11.9 pt-20 -38.9 -47.58 1.45 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -57.52 -46.42 83.83 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.566 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 10.4 t80 -64.99 -37.01 86.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.864 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -64.7 -23.5 67.27 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.783 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 76.9 mtt-85 -59.03 -36.73 75.47 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.566 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 3.1 p90 -115.4 12.62 16.36 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -138.12 -72.23 0.42 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.599 0.238 . . . . 0.0 110.702 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.63 -67.98 0.55 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.715 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.81 75.88 2.57 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.156 2.571 . . . . 0.0 112.732 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--O 1.247 0.974 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.943 179.55 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo . . . . . 0 CA--C 1.53 0.284 0 CA-C-O 120.962 0.318 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.44 12.88 15.32 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.338 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.485 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 1.2 mpt_? . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.942 0.401 . . . . 0.0 111.856 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 C--O 1.232 0.145 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 51.7 t . . . . . 0 N--CA 1.462 0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.354 0.121 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -93.12 109.81 42.13 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.98 -19.9 50.49 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.019 2.479 . . . . 0.0 113.358 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -51.19 -49.55 60.75 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.479 0.181 . . . . 0.0 111.414 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.67 -37.94 55.36 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.352 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -58.45 -30.77 67.2 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.541 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -55.44 -34.75 64.74 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 38.4 tp -54.45 -56.77 15.38 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.626 0.251 . . . . 0.0 110.626 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.24 -12.91 61.92 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.694 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.5 -58.16 3.25 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.483 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -83.62 -15.8 47.62 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.483 HG12 ' CD2' ' A' ' 35' ' ' HIS . 36.3 pt -143.08 147.8 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.883 0.373 . . . . 0.0 111.548 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.91 75.99 1.73 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.765 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.464 ' HB3' ' HG2' ' A' ' 40' ' ' GLU . 6.3 m-85 -118.49 -44.77 2.64 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 59.21 56.67 3.76 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.183 0.516 . . . . 0.0 110.409 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 43' ' ' ARG . 11.5 pt-20 -149.24 40.32 0.86 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.017 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 32' ' ' LEU . . . -86.19 -46.81 10.04 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.633 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.511 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 11.5 t80 -50.21 -44.89 53.4 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.019 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.526 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 18.1 ptp180 -59.21 -32.98 70.44 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -59.0 -36.79 75.52 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 1.7 p90 -117.74 14.45 14.36 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -139.8 -74.22 0.36 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.96 -61.34 0.66 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.276 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.28 104.5 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.866 2.377 . . . . 0.0 113.016 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 43' ' ' ARG . 29.2 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.18 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.233 0.261 0 CA-C-O 120.771 0.238 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.08 44.88 0.49 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.626 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 . . . . . 0 CA--C 1.533 0.292 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.732 179.753 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.5 t . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.538 -179.965 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.403 ' CD1' ' C ' ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.358 0.123 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -79.19 117.8 68.94 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 111.408 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.24 -9.98 24.07 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.899 2.399 . . . . 0.0 113.694 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -50.79 -45.16 59.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.555 0.217 . . . . 0.0 111.234 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.3 p -108.11 -38.57 5.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.665 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.46 -49.04 67.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.565 0.221 . . . . 0.0 111.309 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 36.9 tt0 -82.29 5.94 18.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.611 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.3 tp -59.5 -26.32 65.2 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 122.435 -0.166 . . . . 0.0 111.048 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.669 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -58.48 -19.15 34.61 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -46.81 -45.22 19.91 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.438 0.295 . . . . 0.0 111.62 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.45 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -124.87 -16.81 6.03 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' A' ' 38' ' ' PHE . 20.4 pt -141.08 -54.02 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.669 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 74.34 59.79 3.75 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.002 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.458 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 11.1 m-85 -126.06 178.51 5.73 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.006 0.431 . . . . 0.0 111.207 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 13.73 29.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.145 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 16.1 pt-20 -72.26 -28.92 63.44 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.219 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' ' CE1' ' A' ' 45' ' ' PHE . . . -78.12 -51.72 9.83 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.107 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -43.61 -50.18 7.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.915 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -58.13 -30.9 66.69 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 66.4 mtt-85 -63.22 -43.1 99.06 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.402 ' CE1' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -108.57 20.69 18.25 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -139.97 -63.87 0.49 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.738 0.304 . . . . 0.0 110.646 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.8 156.67 9.47 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.31 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.43 104.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.028 2.486 . . . . 0.0 112.732 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.516 -179.749 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo . . . . . 0 C--O 1.233 0.269 0 CA-C-O 120.932 0.305 . . . . 0.0 112.736 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -111.66 68.79 0.67 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.916 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.407 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.725 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.4 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.564 0.221 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 42' ' ' TYR . 46.9 t . . . . . 0 CA--C 1.533 0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.537 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.558 0.218 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -116.2 83.3 12.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.3 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.64 103.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.129 2.553 . . . . 0.0 113.171 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 54.9 m-20 -146.57 -53.48 0.24 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.296 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.407 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 26.8 p -68.23 -33.29 74.13 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.904 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.59 -34.81 74.76 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -59.23 -28.12 66.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.39 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.408 ' HG ' HG13 ' A' ' 36' ' ' ILE . 28.5 tp -59.41 -36.43 75.84 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.063 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.645 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -59.6 -19.26 47.64 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -53.05 -42.5 65.84 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.42 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -123.56 -16.04 6.89 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.502 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 21.6 pt -140.05 -55.2 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 118.567 0.621 . . . . 0.0 112.577 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.645 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 65.81 70.77 1.02 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.555 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.502 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 8.7 m-85 -122.37 16.88 10.58 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 42.48 34.78 0.57 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.839 0.456 . . . . 0.0 111.822 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -99.92 -25.43 14.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.82 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . . . -60.87 -35.86 77.7 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.975 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.471 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 6.6 t80 -49.3 -42.66 41.99 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.014 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.533 ' HG2' ' HB ' ' A' ' 49' ' ' VAL . 76.4 mtp180 -65.03 -31.73 73.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.647 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.464 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 98.5 mtt180 -56.51 -36.92 69.74 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.893 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 28' ' ' ASP . 2.5 p90 -114.33 23.75 12.54 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.46 ' HE1' ' CE2' ' A' ' 45' ' ' PHE . 21.7 m-85 -140.25 -62.63 0.5 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.632 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.73 -98.3 0.95 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.617 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -65.33 102.17 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.962 2.442 . . . . 0.0 112.084 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.533 ' HB ' ' HG2' ' A' ' 43' ' ' ARG . 34.2 t . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.375 -0.822 . . . . 0.0 111.076 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 C--O 1.233 0.256 0 CA-C-O 121.077 0.366 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -110.28 -14.76 14.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--O 1.232 0.153 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.6 t . . . . . 0 CA--C 1.532 0.285 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.351 179.496 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.589 0.233 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -114.36 82.22 7.33 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.016 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.04 87.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.64 2.894 . . . . 0.0 113.699 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 72.2 m-20 -127.7 -58.75 1.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.622 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 31.1 p -75.85 -43.47 45.58 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.062 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -68.59 -38.77 80.92 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.82 -22.98 65.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.965 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.2 tp -56.92 -26.35 59.15 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.344 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . . . -62.27 -13.7 31.04 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.79 -35.82 61.77 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.11 -9.91 3.79 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.527 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 27.6 pt -138.62 -50.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 118.705 0.684 . . . . 0.0 112.805 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 33' ' ' ALA . . . 81.58 58.62 2.51 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.933 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.527 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 6.8 m-85 -117.97 -35.88 3.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 61.92 28.36 17.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.981 0.419 . . . . 0.0 110.856 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -87.37 -20.6 26.49 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.137 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.84 -28.87 58.48 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.712 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 45' ' ' PHE . 8.6 t80 -43.56 -45.16 6.52 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.522 0.329 . . . . 0.0 111.596 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.424 ' HG2' ' CG2' ' A' ' 49' ' ' VAL . 87.1 mtm180 -56.48 -38.52 71.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.623 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -57.87 -42.06 83.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.39 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 28' ' ' ASP . 2.7 p90 -108.35 17.24 22.37 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.409 ' CE1' ' CD2' ' A' ' 45' ' ' PHE . 28.6 m-85 -142.26 -71.6 0.33 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.483 0.182 . . . . 0.0 110.564 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.61 -72.84 0.39 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.82 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.65 114.1 3.4 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.728 2.285 . . . . 0.0 112.694 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.424 ' CG2' ' HG2' ' A' ' 43' ' ' ARG . 59.4 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.066 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 CA--C 1.532 0.402 0 CA-C-O 120.943 0.309 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -123.96 35.16 4.89 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.277 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.273 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.465 0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.553 179.765 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.444 0.164 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -82.11 115.09 55.5 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.689 0.281 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.95 84.54 1.46 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.778 2.319 . . . . 0.0 112.846 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -156.22 -66.26 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.131 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.8 p -69.02 -43.35 74.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.351 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -70.67 -35.95 73.08 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.465 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -65.49 -31.2 72.15 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.735 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.9 tp -61.14 -31.97 71.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.624 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . . . -84.18 46.63 1.23 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 111.745 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.64 -55.74 1.01 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.534 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.88 -15.75 35.84 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.017 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 40.3 pt -134.38 -43.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 33' ' ' ALA . . . 81.59 64.16 1.78 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.782 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.442 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -127.67 -49.7 1.38 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.442 ' CG ' ' HB3' ' A' ' 33' ' ' ALA . 83.3 mt-30 65.2 25.91 12.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 111.202 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -76.62 -26.95 55.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.255 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.73 67.89 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.542 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 46' ' ' TYR . 4.7 t80 -41.89 -50.09 4.48 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.493 0.317 . . . . 0.0 111.557 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -56.64 -38.91 72.8 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -54.51 -42.74 71.14 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -112.74 22.61 14.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 32.4 m-85 -141.41 -64.94 0.44 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.709 0.29 . . . . 0.0 110.708 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.71 -87.8 0.45 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.055 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.72 78.54 3.31 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.859 2.373 . . . . 0.0 112.184 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.68 -0.676 . . . . 0.0 111.271 -179.701 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo . . . . . 0 CA--C 1.53 0.311 0 CA-C-O 121.11 0.379 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.539 ' HB2' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -70.73 -23.63 62.47 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.583 -179.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HA ' ' HB2' ' A' ' 23' ' ' CYS . 68.6 mtt85 . . . . . 0 N--CA 1.463 0.19 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.3 t . . . . . 0 C--O 1.232 0.142 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 62.0 m . . . . . 0 N--CA 1.465 0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.475 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.372 0.13 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -101.45 106.22 44.66 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.5 -24.5 12.52 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.189 2.593 . . . . 0.0 113.629 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -51.54 -49.07 62.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.593 0.235 . . . . 0.0 111.15 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.6 t -84.65 -35.55 22.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.174 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -56.75 -42.36 79.17 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.661 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.6 -35.53 68.35 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.262 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' A' ' 41' ' ' ALA . 39.8 tp -58.96 -59.53 5.32 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.545 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.14 -25.01 58.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -52.16 -57.96 8.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.538 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -103.42 -17.0 15.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.562 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 24.3 pt -144.87 120.17 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.942 0.401 . . . . 0.0 111.473 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.18 67.83 3.21 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.94 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.562 ' CE2' ' HB ' ' A' ' 36' ' ' ILE . 12.9 m-85 -124.14 -176.52 3.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.933 0.397 . . . . 0.0 110.933 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -137.24 40.44 2.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.276 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -91.42 -45.54 8.5 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.365 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.47 ' HB2' HD13 ' A' ' 32' ' ' LEU . . . -60.33 -42.74 96.27 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.187 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 19' ' ' LYS . 9.0 t80 -44.76 -43.03 8.23 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.496 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 -61.55 -37.41 83.67 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.918 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -55.04 -39.5 69.23 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -113.9 20.39 15.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -138.5 -67.54 0.46 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.481 0.181 . . . . 0.0 110.565 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.65 -101.57 1.86 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.63 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.19 138.51 47.35 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.751 2.3 . . . . 0.0 112.372 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.561 -0.733 . . . . 0.0 111.571 -179.82 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 CA--C 1.53 0.322 0 N-CA-C 112.995 0.344 . . . . 0.0 112.995 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -123.83 24.64 8.3 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.219 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.002 0.429 . . . . 0.0 111.558 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.69 0.281 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.8 t . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.057 179.796 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.369 0.128 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 17.1 p30 -83.38 123.11 77.24 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 111.206 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 24.6 Cg_exo -63.89 -17.84 61.48 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.973 2.449 . . . . 0.0 113.367 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.86 -63.81 0.99 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.545 0.212 . . . . 0.0 111.434 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.424 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 29.2 p -87.9 -29.8 20.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.247 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 53.1 t0 -51.04 -38.42 51.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 37.5 tt0 -82.76 52.03 2.03 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.041 0.448 . . . . 0.0 110.992 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.5 tp -85.95 -37.79 18.66 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.404 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . . . -57.73 -20.76 36.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.907 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 56.6 t0 -46.64 -46.35 19.76 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.415 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -121.62 -19.67 6.78 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 35' ' ' HIS . 13.4 pt -146.78 -56.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 33' ' ' ALA . . . 62.15 57.85 15.25 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.291 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -109.81 -89.76 0.48 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.019 0.41 . . . . 0.0 111.467 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -172.23 43.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.629 0.252 . . . . 0.0 111.65 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 12.6 pt-20 -114.66 -35.5 4.84 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.442 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . . . -50.58 -43.35 56.44 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -63.25 -41.38 99.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.029 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -67.47 -26.32 66.32 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.857 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.442 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 99.4 mtt180 -53.63 -34.26 57.92 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.525 ' CE2' ' HE1' ' A' ' 46' ' ' TYR . 1.5 p90 -123.06 28.94 6.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.525 ' HE1' ' CE2' ' A' ' 45' ' ' PHE . 13.7 m-85 -139.58 -63.64 0.5 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.805 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.401 ' HA3' ' HD3' ' A' ' 48' ' ' PRO . . . 91.99 -104.87 3.22 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.295 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' HA3' ' A' ' 47' ' ' GLY . 29.6 Cg_exo -61.7 131.04 33.66 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.724 2.282 . . . . 0.0 112.137 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.569 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 CA--C 1.529 0.272 0 CA-C-O 120.993 0.33 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -145.48 30.2 1.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.215 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 1.1 mpt_? . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.919 0.39 . . . . 0.0 111.451 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.709 0.29 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 53.2 t . . . . . 0 CA--C 1.528 0.12 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.386 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.355 0.122 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -87.12 112.66 49.25 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 111.298 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.45 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 38.9 Cg_exo -61.28 -14.4 34.04 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.162 2.575 . . . . 0.0 113.792 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.15 -47.84 62.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.495 0.188 . . . . 0.0 110.973 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 25.9 p -100.38 -36.26 9.3 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.003 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.45 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 38.7 t70 -56.73 -48.8 76.95 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.729 0.299 . . . . 0.0 110.59 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 83.2 tt0 -94.52 49.38 1.27 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.127 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 tp -68.23 -31.74 71.45 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.759 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -56.89 -20.49 23.47 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.874 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.502 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 10.2 t70 -46.0 -46.57 16.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.468 0.307 . . . . 0.0 111.543 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.506 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -123.38 -19.31 5.96 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.506 HG12 ' CD2' ' A' ' 35' ' ' HIS . 19.9 pt -144.25 -55.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 118.309 0.504 . . . . 0.0 112.306 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.556 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 68.35 56.84 9.2 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.235 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.496 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 8.4 m-85 -116.16 -84.39 0.63 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.773 0.286 . . . . 0.0 111.17 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 45.5 tt0 170.59 -33.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.289 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -40.56 -44.02 2.0 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.43 -56.6 15.5 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.504 0.192 . . . . 0.0 111.427 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.415 ' O ' ' HB2' ' A' ' 46' ' ' TYR . 4.3 t80 -48.18 -46.69 35.08 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.596 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -58.97 -36.2 74.45 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -52.29 -42.35 63.68 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -118.44 25.34 10.35 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 24.9 m-85 -138.68 -72.67 0.4 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.457 0.17 . . . . 0.0 110.668 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.69 -74.26 0.22 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.646 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.4 120.79 8.8 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.863 2.375 . . . . 0.0 112.376 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.514 -179.787 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 90.3 Cg_endo . . . . . 0 N--CA 1.463 -0.288 0 N-CA-C 113.02 0.354 . . . . 0.0 113.02 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HE3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -142.06 26.32 1.86 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.265 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' NH2' ' HA ' ' A' ' 18' ' ' PRO . 1.1 mpp_? . . . . . 0 C--O 1.234 0.282 0 CA-C-O 120.943 0.402 . . . . 0.0 111.204 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.646 0.26 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 44.3 t . . . . . 0 N--CA 1.462 0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.234 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 3.7 mm? . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -103.31 101.87 25.42 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 120.752 0.31 . . . . 0.0 110.845 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 57.6 Cg_exo -53.2 -21.08 15.98 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.322 2.682 . . . . 0.0 113.917 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -49.67 -47.56 50.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.606 0.241 . . . . 0.0 111.251 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 26.4 p -78.7 -29.47 45.46 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.495 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.46 -23.74 58.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.524 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -47.62 -36.21 10.52 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 36' ' ' ILE . 10.1 mp -57.81 -48.5 79.54 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.519 0.2 . . . . 0.0 111.131 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.55 -25.34 25.42 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.97 -36.52 80.2 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.46 -42.48 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 31.9 pt -102.48 58.98 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 120.987 0.422 . . . . 0.0 111.419 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.96 77.82 0.8 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.762 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.591 ' CE2' ' HB ' ' A' ' 36' ' ' ILE . 16.3 m-85 -93.76 -30.42 14.87 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.32 0.118 . . . . 0.0 111.32 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 66.89 23.1 10.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.915 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 16.1 pt-20 -106.9 -31.12 8.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.67 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.01 -40.12 72.92 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -39.14 -57.6 1.28 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 7.6 ptm180 -55.6 -34.06 64.52 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -59.02 -38.91 80.37 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 29' ' ' CYS . 3.9 p90 -114.15 20.68 15.41 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -139.8 -63.11 0.51 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.776 0.322 . . . . 0.0 110.608 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.73 141.49 3.17 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.113 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.21 111.84 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.867 2.378 . . . . 0.0 112.734 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.531 ' HB ' ' HE3' ' A' ' 19' ' ' LYS . 27.6 m . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.539 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 CA--C 1.533 0.437 0 N-CA-C 113.499 0.538 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 27.6 tptp -150.56 32.77 0.63 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.631 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 1.1 mpp_? . . . . . 0 CA--C 1.532 0.256 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 C--O 1.231 0.102 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.461 0.124 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.709 179.379 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.336 0.112 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -84.59 113.28 48.11 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.796 0.331 . . . . 0.0 111.026 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.15 -16.11 38.11 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.087 2.525 . . . . 0.0 113.633 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -51.58 -53.11 41.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.528 0.204 . . . . 0.0 111.289 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 27.7 p -77.87 -31.71 51.52 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.301 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -62.26 -30.59 71.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.525 0.202 . . . . 0.0 111.161 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.64 -21.52 54.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.565 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.511 HD23 ' HG2' ' A' ' 40' ' ' GLU . 39.7 tp -53.26 -38.46 63.04 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.206 0.202 . . . . 0.0 111.496 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.611 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -57.66 -21.44 40.0 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -51.31 -45.47 62.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.463 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -120.1 -17.63 8.31 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -178.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.538 ' HB ' ' CD1' ' A' ' 38' ' ' PHE . 20.0 pt -142.04 -55.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 118.529 0.604 . . . . 0.0 112.614 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.611 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 62.1 60.72 7.55 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.451 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.538 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 8.0 m-85 -110.93 13.81 22.11 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.704 0.252 . . . . 0.0 111.664 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 58.18 23.28 10.07 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.686 0.279 . . . . 0.0 111.677 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HG2' HD23 ' A' ' 32' ' ' LEU . 12.5 pt-20 -84.61 -11.91 55.05 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.207 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.494 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . . . -77.13 -20.1 56.03 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.599 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.615 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 7.0 t80 -61.42 -46.33 90.58 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.319 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -65.96 -22.31 66.47 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.494 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 99.3 mtt180 -57.4 -34.71 69.16 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.411 0.148 . . . . 0.0 111.226 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.615 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 3.5 p90 -115.17 22.7 13.1 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -138.47 -68.03 0.46 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.785 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.92 -82.78 0.24 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.71 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.43 79.68 3.16 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.931 2.42 . . . . 0.0 112.631 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.749 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo . . . . . 0 C--O 1.233 0.258 0 CA-C-O 120.852 0.271 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -138.89 25.69 2.52 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.552 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.409 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 10.2 mpt_? . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.621 0.248 . . . . 0.0 111.641 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.57 0.224 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 CA--C 1.529 0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.922 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.593 0.235 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . 9.1 p30 -101.64 93.3 3.37 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.957 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 10.4 Cg_endo -53.49 106.95 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.011 2.474 . . . . 0.0 112.921 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 60.6 t0 -159.56 -57.88 0.06 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.138 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 42' ' ' TYR . 28.7 p -71.58 -44.89 63.67 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -74.53 -37.76 62.97 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.19 -22.2 66.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.021 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.416 ' HG ' HG13 ' A' ' 36' ' ' ILE . 36.8 tp -55.44 -27.69 49.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.348 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.601 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . . . -52.64 -22.85 5.56 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -42.75 -47.11 5.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.514 0.325 . . . . 0.0 111.692 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.509 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -124.57 -18.0 5.82 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.509 HG12 ' CD2' ' A' ' 35' ' ' HIS . 16.4 pt -143.79 -56.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.476 0.546 . . . . 0.0 112.476 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' ' 33' ' ' ALA . . . 57.4 71.45 0.74 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.478 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.459 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 10.9 m-85 -117.72 -90.89 0.56 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.8 0.3 . . . . 0.0 111.018 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.408 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 18.2 pt20 -174.79 40.39 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.798 0.333 . . . . 0.0 111.088 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.64 -38.88 5.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.625 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.42 -55.35 34.74 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.353 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.481 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 16.7 t80 -47.92 -41.62 25.12 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.767 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.451 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 77.7 mtp180 -60.92 -36.22 78.73 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -58.77 -36.46 74.42 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.481 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 1.9 p90 -114.83 18.3 16.58 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -142.79 -62.82 0.42 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.651 0.262 . . . . 0.0 110.802 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.16 -73.77 0.41 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.2 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.86 112.33 3.37 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.644 2.23 . . . . 0.0 112.053 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' HB ' ' HD2' ' A' ' 43' ' ' ARG . 12.7 p . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.498 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 CA--C 1.53 0.301 0 CA-C-O 121.032 0.347 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.57 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -111.6 -11.43 14.04 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.426 -179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.57 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 51.1 ttp180 . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 120.932 0.396 . . . . 0.0 111.112 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.531 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 96.3 m . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.35 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.365 0.126 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -103.85 108.45 59.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.867 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 31.4 Cg_exo -60.24 -12.78 21.17 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.109 2.54 . . . . 0.0 113.883 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -47.41 -57.54 5.2 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.484 0.183 . . . . 0.0 111.115 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.471 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 21.3 p -89.4 -24.92 21.8 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.512 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.509 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 8.2 t70 -67.36 -15.45 63.69 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.235 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -47.22 -30.41 2.97 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.9 tp -56.51 -41.51 76.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.543 0.211 . . . . 0.0 111.247 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.666 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -64.5 -14.5 57.56 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -69.07 -47.28 65.68 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.442 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -106.31 -17.47 14.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -178.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.531 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 24.2 pt -141.73 -54.99 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.666 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 61.66 72.88 0.57 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.249 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.531 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 8.8 m-85 -118.84 25.32 10.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 48.31 46.8 20.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 111.222 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.29 14.71 3.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.063 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.14 -59.86 2.17 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.659 0.266 . . . . 0.0 110.802 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -49.69 -24.89 2.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.55 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.427 ' HG2' HG12 ' A' ' 49' ' ' VAL . 76.4 mtp180 -57.16 -57.49 12.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.681 0.277 . . . . 0.0 111.547 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -78.81 -35.27 44.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.471 ' CE2' ' HA ' ' A' ' 29' ' ' CYS . 12.6 m-85 -66.01 -36.34 83.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.09 -67.04 1.03 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.459 0.171 . . . . 0.0 111.235 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.08 -65.22 0.51 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.823 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.63 143.85 82.51 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.775 2.317 . . . . 0.0 112.609 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.562 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . 35.2 m . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.64 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.489 ' CD2' ' HB ' ' A' ' 49' ' ' VAL . 2.8 tm? . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.938 0.399 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . 0.52 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 17' ' ' CGU . 50.2 Cg_exo -54.0 95.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.646 2.231 . . . . 0.0 112.4 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 17' ' ' CGU . 98.9 mttt -116.01 -30.71 5.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.856 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.06 -2.31 9.76 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.33 -34.67 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.739 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.539 ' HB2' ' HD2' ' A' ' 42' ' ' TYR . 41.8 t -52.25 -39.39 60.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.63 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.06 -50.49 19.44 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.283 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -79.05 118.49 72.77 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 111.187 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 33.1 Cg_exo -60.86 -18.68 58.12 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.028 2.485 . . . . 0.0 113.44 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -47.22 -62.28 1.49 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.494 0.188 . . . . 0.0 111.41 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.8 p -98.29 -14.74 20.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.689 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.531 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 38.9 t70 -59.42 -32.2 69.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.598 0.237 . . . . 0.0 110.808 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.86 -22.9 62.91 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.483 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 41' ' ' ALA . 30.4 tp -56.17 -44.98 79.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.157 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -59.75 -19.18 48.63 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.56 -40.77 89.17 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.539 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -114.48 -19.74 11.05 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.539 HG12 ' CD2' ' A' ' 35' ' ' HIS . 19.6 pt -146.45 -55.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 118.437 0.562 . . . . 0.0 112.473 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 62.02 72.34 0.66 Allowed Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.176 -0.535 . . . . 0.0 113.254 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -120.0 -73.0 0.66 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.673 0.236 . . . . 0.0 111.613 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -179.6 -31.47 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 11.9 pt-20 -38.9 -47.58 1.45 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -57.52 -46.42 83.83 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.566 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 10.4 t80 -64.99 -37.01 86.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.864 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -64.7 -23.5 67.27 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.783 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 76.9 mtt-85 -59.03 -36.73 75.47 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.566 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 3.1 p90 -115.4 12.62 16.36 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -138.12 -72.23 0.42 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.599 0.238 . . . . 0.0 110.702 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.63 -67.98 0.55 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.715 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.81 75.88 2.57 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.156 2.571 . . . . 0.0 112.732 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 16' ' ' LEU . 60.1 t . . . . . 0 C--O 1.247 0.974 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.943 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 tp . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.413 0.149 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . 0.511 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.67 90.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.781 2.321 . . . . 0.0 112.373 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 17' ' ' CGU . 97.2 mttt -116.44 12.88 15.32 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.338 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.485 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 1.2 mpt_? -80.98 58.23 3.36 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.942 0.401 . . . . 0.0 111.856 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.36 -36.54 8.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.258 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 51.7 t -54.65 -47.51 73.44 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.66 -50.43 72.54 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.766 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -93.12 109.81 42.13 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.98 -19.9 50.49 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.019 2.479 . . . . 0.0 113.358 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -51.19 -49.55 60.75 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.479 0.181 . . . . 0.0 111.414 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.67 -37.94 55.36 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.352 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -58.45 -30.77 67.2 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.541 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -55.44 -34.75 64.74 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 38.4 tp -54.45 -56.77 15.38 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.626 0.251 . . . . 0.0 110.626 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.24 -12.91 61.92 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.694 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.5 -58.16 3.25 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.483 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -83.62 -15.8 47.62 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.483 HG12 ' CD2' ' A' ' 35' ' ' HIS . 36.3 pt -143.08 147.8 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.883 0.373 . . . . 0.0 111.548 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.91 75.99 1.73 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.765 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.464 ' HB3' ' HG2' ' A' ' 40' ' ' GLU . 6.3 m-85 -118.49 -44.77 2.64 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 59.21 56.67 3.76 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.183 0.516 . . . . 0.0 110.409 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 43' ' ' ARG . 11.5 pt-20 -149.24 40.32 0.86 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.017 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 32' ' ' LEU . . . -86.19 -46.81 10.04 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.633 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.511 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 11.5 t80 -50.21 -44.89 53.4 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.019 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.526 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 18.1 ptp180 -59.21 -32.98 70.44 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -59.0 -36.79 75.52 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 1.7 p90 -117.74 14.45 14.36 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -139.8 -74.22 0.36 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.96 -61.34 0.66 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.276 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.28 104.5 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.866 2.377 . . . . 0.0 113.016 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 43' ' ' ARG . 29.2 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.18 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 17' ' ' CGU . 57.8 tp . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . 0.474 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.3 105.14 1.8 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.69 2.26 . . . . 0.0 112.007 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.08 44.88 0.49 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.626 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -90.91 36.07 0.91 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.732 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.5 t -94.54 -38.67 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.32 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.6 t -50.01 -43.67 50.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.538 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.403 ' CD1' ' C ' ' A' ' 25' ' ' LEU . 3.0 tm? -64.5 -59.42 4.34 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.245 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -79.19 117.8 68.94 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 111.408 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.24 -9.98 24.07 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.899 2.399 . . . . 0.0 113.694 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -50.79 -45.16 59.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.555 0.217 . . . . 0.0 111.234 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.3 p -108.11 -38.57 5.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.665 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.46 -49.04 67.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.565 0.221 . . . . 0.0 111.309 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 36.9 tt0 -82.29 5.94 18.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.611 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.3 tp -59.5 -26.32 65.2 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 122.435 -0.166 . . . . 0.0 111.048 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.669 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -58.48 -19.15 34.61 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -46.81 -45.22 19.91 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.438 0.295 . . . . 0.0 111.62 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.45 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -124.87 -16.81 6.03 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' A' ' 38' ' ' PHE . 20.4 pt -141.08 -54.02 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.669 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 74.34 59.79 3.75 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.002 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.458 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 11.1 m-85 -126.06 178.51 5.73 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.006 0.431 . . . . 0.0 111.207 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 13.73 29.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.145 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 16.1 pt-20 -72.26 -28.92 63.44 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.219 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' ' CE1' ' A' ' 45' ' ' PHE . . . -78.12 -51.72 9.83 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.107 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -43.61 -50.18 7.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.915 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -58.13 -30.9 66.69 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 66.4 mtt-85 -63.22 -43.1 99.06 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.402 ' CE1' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -108.57 20.69 18.25 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -139.97 -63.87 0.49 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.738 0.304 . . . . 0.0 110.646 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.8 156.67 9.47 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.31 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.43 104.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.028 2.486 . . . . 0.0 112.732 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.516 -179.749 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.485 ' CD2' ' HD2' ' A' ' 43' ' ' ARG . 1.1 pp . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.07 96.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.022 2.481 . . . . 0.0 112.736 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -111.66 68.79 0.67 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.916 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.407 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -89.91 16.18 8.63 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.725 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.4 t -81.15 -44.98 21.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 42' ' ' TYR . 46.9 t -56.68 -28.82 61.55 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.537 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.44 -36.73 74.14 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.777 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -116.2 83.3 12.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.3 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.64 103.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.129 2.553 . . . . 0.0 113.171 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 54.9 m-20 -146.57 -53.48 0.24 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.296 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.407 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 26.8 p -68.23 -33.29 74.13 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.904 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.59 -34.81 74.76 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -59.23 -28.12 66.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.39 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.408 ' HG ' HG13 ' A' ' 36' ' ' ILE . 28.5 tp -59.41 -36.43 75.84 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.063 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.645 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -59.6 -19.26 47.64 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -53.05 -42.5 65.84 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.42 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -123.56 -16.04 6.89 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.502 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 21.6 pt -140.05 -55.2 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 118.567 0.621 . . . . 0.0 112.577 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.645 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 65.81 70.77 1.02 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.555 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.502 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 8.7 m-85 -122.37 16.88 10.58 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 42.48 34.78 0.57 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.839 0.456 . . . . 0.0 111.822 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -99.92 -25.43 14.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.82 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . . . -60.87 -35.86 77.7 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.975 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.471 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 6.6 t80 -49.3 -42.66 41.99 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.014 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.533 ' HG2' ' HB ' ' A' ' 49' ' ' VAL . 76.4 mtp180 -65.03 -31.73 73.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.647 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.464 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 98.5 mtt180 -56.51 -36.92 69.74 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.893 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 28' ' ' ASP . 2.5 p90 -114.33 23.75 12.54 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.46 ' HE1' ' CE2' ' A' ' 45' ' ' PHE . 21.7 m-85 -140.25 -62.63 0.5 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.632 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.73 -98.3 0.95 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.617 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -65.33 102.17 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.962 2.442 . . . . 0.0 112.084 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.533 ' HB ' ' HG2' ' A' ' 43' ' ' ARG . 34.2 t . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.375 -0.822 . . . . 0.0 111.076 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.307 0.099 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.58 82.57 0.54 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.666 2.244 . . . . 0.0 112.06 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -110.28 -14.76 14.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -82.11 3.69 26.02 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -87.32 -41.45 14.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.6 t -57.3 -28.86 63.42 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.351 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.71 -34.98 79.09 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.678 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -114.36 82.22 7.33 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.016 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.04 87.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.64 2.894 . . . . 0.0 113.699 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 72.2 m-20 -127.7 -58.75 1.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.622 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 31.1 p -75.85 -43.47 45.58 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.062 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -68.59 -38.77 80.92 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.82 -22.98 65.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.965 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.2 tp -56.92 -26.35 59.15 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.344 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . . . -62.27 -13.7 31.04 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.79 -35.82 61.77 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.11 -9.91 3.79 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.527 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 27.6 pt -138.62 -50.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 118.705 0.684 . . . . 0.0 112.805 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 33' ' ' ALA . . . 81.58 58.62 2.51 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.933 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.527 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 6.8 m-85 -117.97 -35.88 3.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 61.92 28.36 17.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.981 0.419 . . . . 0.0 110.856 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -87.37 -20.6 26.49 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.137 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.84 -28.87 58.48 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.712 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 45' ' ' PHE . 8.6 t80 -43.56 -45.16 6.52 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.522 0.329 . . . . 0.0 111.596 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.424 ' HG2' ' CG2' ' A' ' 49' ' ' VAL . 87.1 mtm180 -56.48 -38.52 71.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.623 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -57.87 -42.06 83.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.39 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 28' ' ' ASP . 2.7 p90 -108.35 17.24 22.37 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.409 ' CE1' ' CD2' ' A' ' 45' ' ' PHE . 28.6 m-85 -142.26 -71.6 0.33 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.483 0.182 . . . . 0.0 110.564 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.61 -72.84 0.39 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.82 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.65 114.1 3.4 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.728 2.285 . . . . 0.0 112.694 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.424 ' CG2' ' HG2' ' A' ' 43' ' ' ARG . 59.4 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.066 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 120.306 0.098 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.73 62.46 8.24 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.647 2.232 . . . . 0.0 112.236 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -123.96 35.16 4.89 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.277 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -95.3 21.0 8.49 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.3 t -84.44 -37.5 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.117 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.9 t -50.2 -40.32 46.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.553 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 25' ' ' LEU . 3.0 tm? -66.44 -55.91 13.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -82.11 115.09 55.5 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.689 0.281 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.95 84.54 1.46 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.778 2.319 . . . . 0.0 112.846 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -156.22 -66.26 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.131 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.8 p -69.02 -43.35 74.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.351 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -70.67 -35.95 73.08 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.465 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -65.49 -31.2 72.15 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.735 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.9 tp -61.14 -31.97 71.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.624 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . . . -84.18 46.63 1.23 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 111.745 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.64 -55.74 1.01 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.534 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.88 -15.75 35.84 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.017 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 40.3 pt -134.38 -43.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 33' ' ' ALA . . . 81.59 64.16 1.78 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.782 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.442 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -127.67 -49.7 1.38 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.442 ' CG ' ' HB3' ' A' ' 33' ' ' ALA . 83.3 mt-30 65.2 25.91 12.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 111.202 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -76.62 -26.95 55.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.255 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.73 67.89 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.542 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 46' ' ' TYR . 4.7 t80 -41.89 -50.09 4.48 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.493 0.317 . . . . 0.0 111.557 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -56.64 -38.91 72.8 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -54.51 -42.74 71.14 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -112.74 22.61 14.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 32.4 m-85 -141.41 -64.94 0.44 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.709 0.29 . . . . 0.0 110.708 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.71 -87.8 0.45 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.055 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.72 78.54 3.31 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.859 2.373 . . . . 0.0 112.184 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.68 -0.676 . . . . 0.0 111.271 -179.701 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.44 ' CD1' ' HB ' ' A' ' 49' ' ' VAL . 55.5 tp . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.869 0.366 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . 0.562 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.562 ' HD2' ' HB2' ' A' ' 17' ' ' CGU . 82.4 Cg_exo -46.1 91.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.804 2.336 . . . . 0.0 112.683 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.539 ' HB2' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -70.73 -23.63 62.47 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.583 -179.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HA ' ' HB2' ' A' ' 23' ' ' CYS . 68.6 mtt85 -56.61 -26.01 54.47 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.3 t -83.52 -38.55 14.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.317 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 62.0 m -51.91 -34.43 41.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.475 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.2 -43.95 31.88 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.104 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -101.45 106.22 44.66 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.5 -24.5 12.52 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.189 2.593 . . . . 0.0 113.629 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -51.54 -49.07 62.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.593 0.235 . . . . 0.0 111.15 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.6 t -84.65 -35.55 22.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.174 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -56.75 -42.36 79.17 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.661 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.6 -35.53 68.35 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.262 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' A' ' 41' ' ' ALA . 39.8 tp -58.96 -59.53 5.32 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.545 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.14 -25.01 58.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -52.16 -57.96 8.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.538 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -103.42 -17.0 15.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.562 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 24.3 pt -144.87 120.17 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.942 0.401 . . . . 0.0 111.473 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.18 67.83 3.21 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.94 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.562 ' CE2' ' HB ' ' A' ' 36' ' ' ILE . 12.9 m-85 -124.14 -176.52 3.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.933 0.397 . . . . 0.0 110.933 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -137.24 40.44 2.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.276 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -91.42 -45.54 8.5 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.365 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.47 ' HB2' HD13 ' A' ' 32' ' ' LEU . . . -60.33 -42.74 96.27 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.187 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 19' ' ' LYS . 9.0 t80 -44.76 -43.03 8.23 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.496 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 -61.55 -37.41 83.67 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.918 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -55.04 -39.5 69.23 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -113.9 20.39 15.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -138.5 -67.54 0.46 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.481 0.181 . . . . 0.0 110.565 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.65 -101.57 1.86 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.63 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.19 138.51 47.35 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.751 2.3 . . . . 0.0 112.372 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.44 ' HB ' ' CD1' ' A' ' 16' ' ' LEU . 35.6 m . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.561 -0.733 . . . . 0.0 111.571 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.54 ' O ' ' HG ' ' A' ' 17' ' ' CGU . 46.5 tp . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 119.934 -0.079 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . 0.649 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 17' ' ' CGU . 18.4 Cg_endo -60.42 101.53 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.79 2.327 . . . . 0.0 112.995 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HB3' OE21 ' A' ' 17' ' ' CGU . 19.4 ptpt -123.83 24.64 8.3 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.219 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -78.42 65.3 3.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.002 0.429 . . . . 0.0 111.558 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t -87.39 -37.65 11.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.311 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.8 t -57.71 -40.14 78.86 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.057 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.12 -54.13 48.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.932 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 17.1 p30 -83.38 123.11 77.24 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 111.206 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 24.6 Cg_exo -63.89 -17.84 61.48 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.973 2.449 . . . . 0.0 113.367 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.86 -63.81 0.99 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.545 0.212 . . . . 0.0 111.434 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.424 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 29.2 p -87.9 -29.8 20.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.247 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 53.1 t0 -51.04 -38.42 51.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 37.5 tt0 -82.76 52.03 2.03 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.041 0.448 . . . . 0.0 110.992 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.5 tp -85.95 -37.79 18.66 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.404 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . . . -57.73 -20.76 36.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.907 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 56.6 t0 -46.64 -46.35 19.76 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.415 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.555 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -121.62 -19.67 6.78 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 35' ' ' HIS . 13.4 pt -146.78 -56.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 33' ' ' ALA . . . 62.15 57.85 15.25 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.291 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -109.81 -89.76 0.48 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.019 0.41 . . . . 0.0 111.467 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -172.23 43.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.629 0.252 . . . . 0.0 111.65 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 12.6 pt-20 -114.66 -35.5 4.84 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.442 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . . . -50.58 -43.35 56.44 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -63.25 -41.38 99.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.029 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -67.47 -26.32 66.32 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.857 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.442 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 99.4 mtt180 -53.63 -34.26 57.92 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.525 ' CE2' ' HE1' ' A' ' 46' ' ' TYR . 1.5 p90 -123.06 28.94 6.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.525 ' HE1' ' CE2' ' A' ' 45' ' ' PHE . 13.7 m-85 -139.58 -63.64 0.5 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.805 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.401 ' HA3' ' HD3' ' A' ' 48' ' ' PRO . . . 91.99 -104.87 3.22 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.295 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' HA3' ' A' ' 47' ' ' GLY . 29.6 Cg_exo -61.7 131.04 33.66 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.724 2.282 . . . . 0.0 112.137 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.569 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.7 tp . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.453 0.168 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.87 90.62 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.653 2.236 . . . . 0.0 112.298 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -145.48 30.2 1.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.215 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 1.1 mpt_? -93.67 63.27 3.37 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.919 0.39 . . . . 0.0 111.451 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.5 t -86.02 -39.21 13.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.362 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 53.2 t -55.04 -41.83 71.88 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.386 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.01 -55.39 33.44 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.073 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -87.12 112.66 49.25 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 111.298 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.45 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 38.9 Cg_exo -61.28 -14.4 34.04 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.162 2.575 . . . . 0.0 113.792 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.15 -47.84 62.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.495 0.188 . . . . 0.0 110.973 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 25.9 p -100.38 -36.26 9.3 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.003 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.45 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 38.7 t70 -56.73 -48.8 76.95 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.729 0.299 . . . . 0.0 110.59 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 83.2 tt0 -94.52 49.38 1.27 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.127 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 tp -68.23 -31.74 71.45 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.759 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -56.89 -20.49 23.47 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.874 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.502 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 10.2 t70 -46.0 -46.57 16.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.468 0.307 . . . . 0.0 111.543 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.506 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -123.38 -19.31 5.96 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.506 HG12 ' CD2' ' A' ' 35' ' ' HIS . 19.9 pt -144.25 -55.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 118.309 0.504 . . . . 0.0 112.306 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.556 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 68.35 56.84 9.2 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.235 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.496 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 8.4 m-85 -116.16 -84.39 0.63 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.773 0.286 . . . . 0.0 111.17 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 45.5 tt0 170.59 -33.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.289 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -40.56 -44.02 2.0 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.43 -56.6 15.5 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.504 0.192 . . . . 0.0 111.427 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.415 ' O ' ' HB2' ' A' ' 46' ' ' TYR . 4.3 t80 -48.18 -46.69 35.08 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.596 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -58.97 -36.2 74.45 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -52.29 -42.35 63.68 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -118.44 25.34 10.35 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 24.9 m-85 -138.68 -72.67 0.4 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.457 0.17 . . . . 0.0 110.668 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.69 -74.26 0.22 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.646 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.4 120.79 8.8 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.863 2.375 . . . . 0.0 112.376 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.514 -179.787 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.0 tp . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.452 0.168 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 90.3 Cg_endo -83.43 124.8 3.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.814 2.343 . . . . 0.0 113.02 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HE3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -142.06 26.32 1.86 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.265 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' NH2' ' HA ' ' A' ' 18' ' ' PRO . 1.1 mpp_? -84.77 55.95 3.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.943 0.402 . . . . 0.0 111.204 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . 0.416 OE21 ' HA ' ' A' ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.67 -32.37 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.384 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 44.3 t -51.05 -46.87 61.79 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.234 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 3.7 mm? -63.82 -39.91 95.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.521 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -103.31 101.87 25.42 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 120.752 0.31 . . . . 0.0 110.845 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 57.6 Cg_exo -53.2 -21.08 15.98 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.322 2.682 . . . . 0.0 113.917 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -49.67 -47.56 50.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.606 0.241 . . . . 0.0 111.251 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 26.4 p -78.7 -29.47 45.46 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.495 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.46 -23.74 58.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.524 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -47.62 -36.21 10.52 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 36' ' ' ILE . 10.1 mp -57.81 -48.5 79.54 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.519 0.2 . . . . 0.0 111.131 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.55 -25.34 25.42 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.97 -36.52 80.2 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.46 -42.48 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 31.9 pt -102.48 58.98 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 120.987 0.422 . . . . 0.0 111.419 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.96 77.82 0.8 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.762 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.591 ' CE2' ' HB ' ' A' ' 36' ' ' ILE . 16.3 m-85 -93.76 -30.42 14.87 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.32 0.118 . . . . 0.0 111.32 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 66.89 23.1 10.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.915 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 16.1 pt-20 -106.9 -31.12 8.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.67 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.01 -40.12 72.92 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -39.14 -57.6 1.28 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 7.6 ptm180 -55.6 -34.06 64.52 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -59.02 -38.91 80.37 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 29' ' ' CYS . 3.9 p90 -114.15 20.68 15.41 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -139.8 -63.11 0.51 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.776 0.322 . . . . 0.0 110.608 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.73 141.49 3.17 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.113 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.21 111.84 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.867 2.378 . . . . 0.0 112.734 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.531 ' HB ' ' HE3' ' A' ' 19' ' ' LYS . 27.6 m . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.539 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 17' ' ' CGU . 58.1 tp . . . . . 0 N--CA 1.463 0.212 0 N-CA-C 110.925 -0.028 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . 0.617 ' C ' ' CD2' ' A' ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 17' ' ' CGU . 94.0 Cg_endo -89.01 84.4 0.58 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.967 2.445 . . . . 0.0 113.499 -178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HB2' OE22 ' A' ' 17' ' ' CGU . 27.6 tptp -150.56 32.77 0.63 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.631 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 1.1 mpp_? -90.04 7.04 39.67 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.4 t -76.57 -48.0 27.86 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.9 t -56.05 -44.62 79.01 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.709 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.14 -54.27 19.22 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.792 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -84.59 113.28 48.11 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.796 0.331 . . . . 0.0 111.026 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.15 -16.11 38.11 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.087 2.525 . . . . 0.0 113.633 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -51.58 -53.11 41.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.528 0.204 . . . . 0.0 111.289 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 27.7 p -77.87 -31.71 51.52 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.301 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -62.26 -30.59 71.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.525 0.202 . . . . 0.0 111.161 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.64 -21.52 54.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.565 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.511 HD23 ' HG2' ' A' ' 40' ' ' GLU . 39.7 tp -53.26 -38.46 63.04 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.206 0.202 . . . . 0.0 111.496 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.611 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -57.66 -21.44 40.0 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -51.31 -45.47 62.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.463 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -120.1 -17.63 8.31 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -178.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.538 ' HB ' ' CD1' ' A' ' 38' ' ' PHE . 20.0 pt -142.04 -55.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 118.529 0.604 . . . . 0.0 112.614 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.611 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 62.1 60.72 7.55 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.451 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.538 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 8.0 m-85 -110.93 13.81 22.11 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.704 0.252 . . . . 0.0 111.664 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 58.18 23.28 10.07 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.686 0.279 . . . . 0.0 111.677 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' HG2' HD23 ' A' ' 32' ' ' LEU . 12.5 pt-20 -84.61 -11.91 55.05 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.207 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.494 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . . . -77.13 -20.1 56.03 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.599 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.615 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 7.0 t80 -61.42 -46.33 90.58 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.319 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -65.96 -22.31 66.47 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.494 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 99.3 mtt180 -57.4 -34.71 69.16 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.411 0.148 . . . . 0.0 111.226 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.615 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 3.5 p90 -115.17 22.7 13.1 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -138.47 -68.03 0.46 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.785 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.92 -82.78 0.24 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.71 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.43 79.68 3.16 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.931 2.42 . . . . 0.0 112.631 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.749 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.05 105.16 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.706 2.271 . . . . 0.0 112.46 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -138.89 25.69 2.52 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.552 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.409 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 10.2 mpt_? -96.95 33.67 1.86 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.621 0.248 . . . . 0.0 111.641 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.89 -36.85 8.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.701 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.3 t -62.21 -31.14 71.63 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.62 -43.05 94.98 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.423 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . 9.1 p30 -101.64 93.3 3.37 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.957 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 10.4 Cg_endo -53.49 106.95 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.011 2.474 . . . . 0.0 112.921 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 60.6 t0 -159.56 -57.88 0.06 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.138 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 42' ' ' TYR . 28.7 p -71.58 -44.89 63.67 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -74.53 -37.76 62.97 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.19 -22.2 66.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.021 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.416 ' HG ' HG13 ' A' ' 36' ' ' ILE . 36.8 tp -55.44 -27.69 49.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.348 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.601 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . . . -52.64 -22.85 5.56 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -42.75 -47.11 5.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.514 0.325 . . . . 0.0 111.692 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.509 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -124.57 -18.0 5.82 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.509 HG12 ' CD2' ' A' ' 35' ' ' HIS . 16.4 pt -143.79 -56.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.476 0.546 . . . . 0.0 112.476 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' ' 33' ' ' ALA . . . 57.4 71.45 0.74 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.478 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.459 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 10.9 m-85 -117.72 -90.89 0.56 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.8 0.3 . . . . 0.0 111.018 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.408 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 18.2 pt20 -174.79 40.39 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.798 0.333 . . . . 0.0 111.088 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.64 -38.88 5.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.625 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.42 -55.35 34.74 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.353 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.481 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 16.7 t80 -47.92 -41.62 25.12 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.767 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.451 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 77.7 mtp180 -60.92 -36.22 78.73 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -58.77 -36.46 74.42 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.481 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 1.9 p90 -114.83 18.3 16.58 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -142.79 -62.82 0.42 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.651 0.262 . . . . 0.0 110.802 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.16 -73.77 0.41 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.2 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.86 112.33 3.37 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.644 2.23 . . . . 0.0 112.053 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' HB ' ' HD2' ' A' ' 43' ' ' ARG . 12.7 p . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.498 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.481 ' CD1' ' HE3' ' A' ' 19' ' ' LYS . 3.4 tm? . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.374 0.13 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CGU . . . . . 0.44 ' HG ' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HD2' ' HG ' ' A' ' 17' ' ' CGU . 40.3 Cg_endo -66.28 85.47 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.558 2.172 . . . . 0.0 111.932 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.57 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -111.6 -11.43 14.04 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.426 -179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.57 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 51.1 ttp180 -93.26 34.33 1.15 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.932 0.396 . . . . 0.0 111.112 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.3 t -64.72 -42.86 96.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.425 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.531 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 96.3 m -52.67 -35.11 54.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.35 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.02 -48.5 8.61 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.732 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -103.85 108.45 59.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.867 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 31.4 Cg_exo -60.24 -12.78 21.17 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.109 2.54 . . . . 0.0 113.883 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -47.41 -57.54 5.2 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.484 0.183 . . . . 0.0 111.115 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.471 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 21.3 p -89.4 -24.92 21.8 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.512 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.509 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 8.2 t70 -67.36 -15.45 63.69 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.235 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -47.22 -30.41 2.97 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.9 tp -56.51 -41.51 76.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.543 0.211 . . . . 0.0 111.247 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.666 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -64.5 -14.5 57.56 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -69.07 -47.28 65.68 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.442 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -106.31 -17.47 14.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -178.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.531 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 24.2 pt -141.73 -54.99 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.666 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 61.66 72.88 0.57 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.249 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.531 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 8.8 m-85 -118.84 25.32 10.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 48.31 46.8 20.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 111.222 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.29 14.71 3.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.063 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.14 -59.86 2.17 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.659 0.266 . . . . 0.0 110.802 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -49.69 -24.89 2.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.55 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.469 ' HD2' HD23 ' A' ' 16' ' ' LEU . 76.4 mtp180 -57.16 -57.49 12.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.681 0.277 . . . . 0.0 111.547 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -78.81 -35.27 44.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.471 ' CE2' ' HA ' ' A' ' 29' ' ' CYS . 12.6 m-85 -66.01 -36.34 83.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.09 -67.04 1.03 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.459 0.171 . . . . 0.0 111.235 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.08 -65.22 0.51 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.823 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.63 143.85 82.51 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.775 2.317 . . . . 0.0 112.609 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.562 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . 35.2 m . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.64 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 CA--C 1.531 0.327 0 CA-C-O 120.935 0.306 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . 98.9 mttt -116.01 -30.71 5.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.856 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.655 0.264 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.552 ' HB2' ' HD2' ' A' ' 42' ' ' TYR . 41.8 t . . . . . 0 N--CA 1.464 0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.63 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.4 mm? . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.382 0.134 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' ND2' ' SG ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -79.05 118.49 72.77 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 111.187 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.611 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 33.1 Cg_exo -60.86 -18.68 58.12 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.028 2.485 . . . . 0.0 113.44 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -47.22 -62.28 1.49 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.494 0.188 . . . . 0.0 111.41 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.447 ' SG ' ' ND2' ' A' ' 26' ' ' ASN . 25.8 p -98.29 -14.74 20.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.689 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.611 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 38.9 t70 -59.42 -32.2 69.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.598 0.237 . . . . 0.0 110.808 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.86 -22.9 62.91 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.483 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.864 HD11 HD11 ' A' ' 36' ' ' ILE . 30.4 tp -56.17 -44.98 79.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.157 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.545 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -59.75 -19.18 48.63 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.56 -40.77 89.17 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.48 -19.74 11.05 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.864 HD11 HD11 ' A' ' 32' ' ' LEU . 19.6 pt -146.45 -55.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 118.437 0.562 . . . . 0.0 112.473 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 62.02 72.34 0.66 Allowed Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.176 -0.535 . . . . 0.0 113.254 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -120.0 -73.0 0.66 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.673 0.236 . . . . 0.0 111.613 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.438 ' OE1' HG22 ' A' ' 49' ' ' VAL . 22.1 pt20 -179.6 -31.47 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 11.9 pt-20 -38.9 -47.58 1.45 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.539 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -57.52 -46.42 83.83 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 10.4 t80 -64.99 -37.01 86.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.864 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.465 ' HA ' ' H ' ' A' ' 47' ' ' GLY . 76.2 mtp180 -64.7 -23.5 67.27 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.783 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 76.9 mtt-85 -59.03 -36.73 75.47 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.582 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 3.1 p90 -115.4 12.62 16.36 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -138.12 -72.23 0.42 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.599 0.238 . . . . 0.0 110.702 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.465 ' H ' ' HA ' ' A' ' 43' ' ' ARG . . . 129.63 -67.98 0.55 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.715 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.81 75.88 2.57 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.156 2.571 . . . . 0.0 112.732 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.438 HG22 ' OE1' ' A' ' 39' ' ' GLN . 60.1 t . . . . . 0 C--O 1.247 0.974 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.943 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo . . . . . 0 CA--C 1.53 0.284 0 CA-C-O 120.962 0.318 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.44 12.88 15.32 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.338 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.499 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 1.2 mpt_? . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.942 0.401 . . . . 0.0 111.856 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 C--O 1.232 0.145 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 51.7 t . . . . . 0 N--CA 1.462 0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.607 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.354 0.121 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -93.12 109.81 42.13 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.98 -19.9 50.49 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.019 2.479 . . . . 0.0 113.358 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -51.19 -49.55 60.75 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.479 0.181 . . . . 0.0 111.414 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.67 -37.94 55.36 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.352 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -58.45 -30.77 67.2 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.541 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -55.44 -34.75 64.74 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.74 ' CD1' HD11 ' A' ' 36' ' ' ILE . 38.4 tp -54.45 -56.77 15.38 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.626 0.251 . . . . 0.0 110.626 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.24 -12.91 61.92 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.694 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.5 -58.16 3.25 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -15.8 47.62 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.74 HD11 ' CD1' ' A' ' 32' ' ' LEU . 36.3 pt -143.08 147.8 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.883 0.373 . . . . 0.0 111.548 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.91 75.99 1.73 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.765 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.5 ' CD1' HD12 ' A' ' 36' ' ' ILE . 6.3 m-85 -118.49 -44.77 2.64 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 59.21 56.67 3.76 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.183 0.516 . . . . 0.0 110.409 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 43' ' ' ARG . 11.5 pt-20 -149.24 40.32 0.86 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.017 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 32' ' ' LEU . . . -86.19 -46.81 10.04 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.633 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.53 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 11.5 t80 -50.21 -44.89 53.4 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.019 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.605 ' HB3' HG11 ' A' ' 49' ' ' VAL . 18.1 ptp180 -59.21 -32.98 70.44 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -59.0 -36.79 75.52 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 1.7 p90 -117.74 14.45 14.36 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -139.8 -74.22 0.36 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.404 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . 129.96 -61.34 0.66 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.276 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 47' ' ' GLY . 18.4 Cg_endo -58.28 104.5 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.866 2.377 . . . . 0.0 113.016 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.605 HG11 ' HB3' ' A' ' 43' ' ' ARG . 29.2 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.18 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.233 0.261 0 CA-C-O 120.771 0.238 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.08 44.88 0.49 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.626 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 . . . . . 0 CA--C 1.533 0.292 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.732 179.753 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.5 t . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.538 -179.965 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.625 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.358 0.123 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -79.19 117.8 68.94 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 111.408 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.24 -9.98 24.07 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.899 2.399 . . . . 0.0 113.694 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -50.79 -45.16 59.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.555 0.217 . . . . 0.0 111.234 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.3 p -108.11 -38.57 5.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.665 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.46 -49.04 67.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.565 0.221 . . . . 0.0 111.309 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 36.9 tt0 -82.29 5.94 18.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.611 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 36' ' ' ILE . 31.3 tp -59.5 -26.32 65.2 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 122.435 -0.166 . . . . 0.0 111.048 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.673 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -58.48 -19.15 34.61 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -46.81 -45.22 19.91 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.438 0.295 . . . . 0.0 111.62 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -16.81 6.03 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 32' ' ' LEU . 20.4 pt -141.08 -54.02 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.673 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 74.34 59.79 3.75 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.002 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' O ' HD23 ' A' ' 32' ' ' LEU . 11.1 m-85 -126.06 178.51 5.73 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.006 0.431 . . . . 0.0 111.207 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 13.73 29.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.145 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 16.1 pt-20 -72.26 -28.92 63.44 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.219 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.481 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -78.12 -51.72 9.83 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.107 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -43.61 -50.18 7.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.915 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.541 ' HB3' HG22 ' A' ' 49' ' ' VAL . 39.6 ptt180 -58.13 -30.9 66.69 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 66.4 mtt-85 -63.22 -43.1 99.06 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.402 ' CE1' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -108.57 20.69 18.25 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -139.97 -63.87 0.49 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.738 0.304 . . . . 0.0 110.646 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.8 156.67 9.47 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.31 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.43 104.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.028 2.486 . . . . 0.0 112.732 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 43' ' ' ARG . 28.6 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.516 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 48.6 Cg_exo . . . . . 0 C--O 1.233 0.269 0 CA-C-O 120.932 0.305 . . . . 0.0 112.736 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -111.66 68.79 0.67 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.916 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.427 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.725 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.4 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.564 0.221 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 42' ' ' TYR . 46.9 t . . . . . 0 CA--C 1.533 0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.537 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.558 0.218 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -116.2 83.3 12.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.3 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.64 103.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.129 2.553 . . . . 0.0 113.171 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 54.9 m-20 -146.57 -53.48 0.24 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.296 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 26.8 p -68.23 -33.29 74.13 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.904 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.59 -34.81 74.76 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -59.23 -28.12 66.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.39 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.016 HD11 HD11 ' A' ' 36' ' ' ILE . 28.5 tp -59.41 -36.43 75.84 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.063 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.65 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -59.6 -19.26 47.64 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -53.05 -42.5 65.84 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 -16.04 6.89 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.016 HD11 HD11 ' A' ' 32' ' ' LEU . 21.6 pt -140.05 -55.2 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 118.567 0.621 . . . . 0.0 112.577 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.65 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 65.81 70.77 1.02 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.555 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 8.7 m-85 -122.37 16.88 10.58 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 42.48 34.78 0.57 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.839 0.456 . . . . 0.0 111.822 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.617 ' HG2' HD21 ' A' ' 32' ' ' LEU . 11.8 pt-20 -99.92 -25.43 14.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.82 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.545 ' H ' HD22 ' A' ' 32' ' ' LEU . . . -60.87 -35.86 77.7 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.975 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.48 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 6.6 t80 -49.3 -42.66 41.99 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.014 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.552 ' HG2' ' HB ' ' A' ' 49' ' ' VAL . 76.4 mtp180 -65.03 -31.73 73.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.647 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.477 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 98.5 mtt180 -56.51 -36.92 69.74 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.893 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 28' ' ' ASP . 2.5 p90 -114.33 23.75 12.54 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.46 ' HE1' ' CE2' ' A' ' 45' ' ' PHE . 21.7 m-85 -140.25 -62.63 0.5 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.632 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 48' ' ' PRO . . . 112.73 -98.3 0.95 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.617 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HD3' ' HA3' ' A' ' 47' ' ' GLY . 20.9 Cg_exo -65.33 102.17 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.962 2.442 . . . . 0.0 112.084 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.552 ' HB ' ' HG2' ' A' ' 43' ' ' ARG . 34.2 t . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.375 -0.822 . . . . 0.0 111.076 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 C--O 1.233 0.256 0 CA-C-O 121.077 0.366 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -110.28 -14.76 14.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.416 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--O 1.232 0.153 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.6 t . . . . . 0 CA--C 1.532 0.285 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.351 179.496 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.45 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.589 0.233 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -114.36 82.22 7.33 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.016 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.04 87.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.64 2.894 . . . . 0.0 113.699 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 72.2 m-20 -127.7 -58.75 1.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.622 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 31.1 p -75.85 -43.47 45.58 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.062 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -68.59 -38.77 80.92 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.82 -22.98 65.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.965 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.523 ' CG ' HD11 ' A' ' 36' ' ' ILE . 37.2 tp -56.92 -26.35 59.15 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.344 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.633 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . . . -62.27 -13.7 31.04 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.79 -35.82 61.77 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.11 -9.91 3.79 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.542 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 27.6 pt -138.62 -50.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 118.705 0.684 . . . . 0.0 112.805 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 33' ' ' ALA . . . 81.58 58.62 2.51 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.933 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.542 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 6.8 m-85 -117.97 -35.88 3.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.451 ' H ' HD23 ' A' ' 32' ' ' LEU . 0.8 OUTLIER 61.92 28.36 17.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.981 0.419 . . . . 0.0 110.856 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -87.37 -20.6 26.49 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.137 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.84 -28.87 58.48 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.712 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 45' ' ' PHE . 8.6 t80 -43.56 -45.16 6.52 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.522 0.329 . . . . 0.0 111.596 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.451 ' HG2' ' CG2' ' A' ' 49' ' ' VAL . 87.1 mtm180 -56.48 -38.52 71.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.623 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -57.87 -42.06 83.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.39 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 28' ' ' ASP . 2.7 p90 -108.35 17.24 22.37 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.409 ' CE1' ' CD2' ' A' ' 45' ' ' PHE . 28.6 m-85 -142.26 -71.6 0.33 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.483 0.182 . . . . 0.0 110.564 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.61 -72.84 0.39 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.82 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.65 114.1 3.4 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.728 2.285 . . . . 0.0 112.694 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 43' ' ' ARG . 59.4 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.066 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 CA--C 1.532 0.402 0 CA-C-O 120.943 0.309 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -123.96 35.16 4.89 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.277 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.273 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.465 0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.553 179.765 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.614 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.444 0.164 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -82.11 115.09 55.5 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.689 0.281 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.95 84.54 1.46 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.778 2.319 . . . . 0.0 112.846 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -156.22 -66.26 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.131 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.8 p -69.02 -43.35 74.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.351 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -70.67 -35.95 73.08 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.465 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -65.49 -31.2 72.15 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.735 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.628 HD11 HD11 ' A' ' 36' ' ' ILE . 34.9 tp -61.14 -31.97 71.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.738 ' HB2' ' HG3' ' A' ' 39' ' ' GLN . . . -84.18 46.63 1.23 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 111.745 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.64 -55.74 1.01 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.534 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.88 -15.75 35.84 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.017 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.628 HD11 HD11 ' A' ' 32' ' ' LEU . 40.3 pt -134.38 -43.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 33' ' ' ALA . . . 81.59 64.16 1.78 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.782 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.46 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -127.67 -49.7 1.38 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.738 ' HG3' ' HB2' ' A' ' 33' ' ' ALA . 83.3 mt-30 65.2 25.91 12.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 111.202 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -76.62 -26.95 55.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.255 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.493 ' HB1' ' HE1' ' A' ' 45' ' ' PHE . . . -56.32 -35.73 67.89 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.542 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -41.89 -50.09 4.48 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.493 0.317 . . . . 0.0 111.557 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -56.64 -38.91 72.8 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -54.51 -42.74 71.14 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' HE1' ' HB1' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -112.74 22.61 14.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -141.41 -64.94 0.44 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.709 0.29 . . . . 0.0 110.708 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.71 -87.8 0.45 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.055 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.72 78.54 3.31 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.859 2.373 . . . . 0.0 112.184 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.68 -0.676 . . . . 0.0 111.271 -179.701 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo . . . . . 0 CA--C 1.53 0.311 0 CA-C-O 121.11 0.379 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -70.73 -23.63 62.47 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.583 -179.408 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HA ' ' HB2' ' A' ' 23' ' ' CYS . 68.6 mtt85 . . . . . 0 N--CA 1.463 0.19 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.3 t . . . . . 0 C--O 1.232 0.142 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 62.0 m . . . . . 0 N--CA 1.465 0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.475 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.1 mm? . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.372 0.13 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -101.45 106.22 44.66 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 72.8 Cg_exo -50.5 -24.5 12.52 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.189 2.593 . . . . 0.0 113.629 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -51.54 -49.07 62.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.593 0.235 . . . . 0.0 111.15 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.408 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 44.6 t -84.65 -35.55 22.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.174 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.422 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 10.5 t70 -56.75 -42.36 79.17 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.661 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.6 -35.53 68.35 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.262 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.562 ' CD1' HD11 ' A' ' 36' ' ' ILE . 39.8 tp -58.96 -59.53 5.32 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.545 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.14 -25.01 58.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -52.16 -57.96 8.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.42 -17.0 15.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.57 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 24.3 pt -144.87 120.17 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.942 0.401 . . . . 0.0 111.473 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.18 67.83 3.21 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.94 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.57 ' CE2' ' HB ' ' A' ' 36' ' ' ILE . 12.9 m-85 -124.14 -176.52 3.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.933 0.397 . . . . 0.0 110.933 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -137.24 40.44 2.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.276 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -91.42 -45.54 8.5 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.365 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.536 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -60.33 -42.74 96.27 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.187 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 19' ' ' LYS . 9.0 t80 -44.76 -43.03 8.23 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.496 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.491 ' CZ ' HG11 ' A' ' 49' ' ' VAL . 57.8 mmt-85 -61.55 -37.41 83.67 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.918 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -55.04 -39.5 69.23 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -113.9 20.39 15.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -138.5 -67.54 0.46 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.481 0.181 . . . . 0.0 110.565 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.65 -101.57 1.86 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.63 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.19 138.51 47.35 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.751 2.3 . . . . 0.0 112.372 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.491 HG11 ' CZ ' ' A' ' 43' ' ' ARG . 35.6 m . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.561 -0.733 . . . . 0.0 111.571 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 CA--C 1.53 0.322 0 N-CA-C 112.995 0.344 . . . . 0.0 112.995 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -123.83 24.64 8.3 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.219 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.002 0.429 . . . . 0.0 111.558 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.69 0.281 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.8 t . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.057 179.796 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.369 0.128 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.474 ' ND2' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -83.38 123.11 77.24 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 111.206 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 24.6 Cg_exo -63.89 -17.84 61.48 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.973 2.449 . . . . 0.0 113.367 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.86 -63.81 0.99 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.545 0.212 . . . . 0.0 111.434 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.675 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 29.2 p -87.9 -29.8 20.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.247 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.532 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 53.1 t0 -51.04 -38.42 51.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 37.5 tt0 -82.76 52.03 2.03 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.041 0.448 . . . . 0.0 110.992 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.822 HD13 ' HB2' ' A' ' 41' ' ' ALA . 52.5 tp -85.95 -37.79 18.66 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.404 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.54 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . . . -57.73 -20.76 36.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.907 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 56.6 t0 -46.64 -46.35 19.76 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.415 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 -19.67 6.78 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 32' ' ' LEU . 13.4 pt -146.78 -56.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 33' ' ' ALA . . . 62.15 57.85 15.25 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.291 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.52 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -109.81 -89.76 0.48 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.019 0.41 . . . . 0.0 111.467 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -172.23 43.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.629 0.252 . . . . 0.0 111.65 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 12.6 pt-20 -114.66 -35.5 4.84 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.822 ' HB2' HD13 ' A' ' 32' ' ' LEU . . . -50.58 -43.35 56.44 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -63.25 -41.38 99.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.029 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -67.47 -26.32 66.32 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.857 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.462 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 99.4 mtt180 -53.63 -34.26 57.92 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CE2' ' HE1' ' A' ' 46' ' ' TYR . 1.5 p90 -123.06 28.94 6.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.526 ' HE1' ' CE2' ' A' ' 45' ' ' PHE . 13.7 m-85 -139.58 -63.64 0.5 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.805 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.413 ' HA3' ' HD3' ' A' ' 48' ' ' PRO . . . 91.99 -104.87 3.22 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.295 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HD3' ' HA3' ' A' ' 47' ' ' GLY . 29.6 Cg_exo -61.7 131.04 33.66 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.724 2.282 . . . . 0.0 112.137 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.569 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 CA--C 1.529 0.272 0 CA-C-O 120.993 0.33 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -145.48 30.2 1.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.215 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 1.1 mpt_? . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.919 0.39 . . . . 0.0 111.451 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.709 0.29 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 53.2 t . . . . . 0 CA--C 1.528 0.12 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.386 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.616 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.355 0.122 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.6 p-10 -87.12 112.66 49.25 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 111.298 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 38.9 Cg_exo -61.28 -14.4 34.04 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.162 2.575 . . . . 0.0 113.792 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.15 -47.84 62.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.495 0.188 . . . . 0.0 110.973 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 25.9 p -100.38 -36.26 9.3 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.003 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.515 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 38.7 t70 -56.73 -48.8 76.95 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.729 0.299 . . . . 0.0 110.59 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 83.2 tt0 -94.52 49.38 1.27 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.127 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.71 HD11 HD11 ' A' ' 36' ' ' ILE . 31.8 tp -68.23 -31.74 71.45 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.759 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.561 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -56.89 -20.49 23.47 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.874 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.515 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 10.2 t70 -46.0 -46.57 16.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.468 0.307 . . . . 0.0 111.543 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.38 -19.31 5.96 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.71 HD11 HD11 ' A' ' 32' ' ' LEU . 19.9 pt -144.25 -55.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 118.309 0.504 . . . . 0.0 112.306 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 68.35 56.84 9.2 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.235 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 8.4 m-85 -116.16 -84.39 0.63 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.773 0.286 . . . . 0.0 111.17 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.489 ' NE2' HG23 ' A' ' 49' ' ' VAL . 45.5 tt0 170.59 -33.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.289 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -40.56 -44.02 2.0 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.43 -56.6 15.5 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.504 0.192 . . . . 0.0 111.427 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.415 ' O ' ' HB2' ' A' ' 46' ' ' TYR . 4.3 t80 -48.18 -46.69 35.08 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.596 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.408 HH21 HG21 ' A' ' 49' ' ' VAL . 99.0 mtt180 -58.97 -36.2 74.45 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -52.29 -42.35 63.68 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -118.44 25.34 10.35 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 24.9 m-85 -138.68 -72.67 0.4 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.457 0.17 . . . . 0.0 110.668 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.69 -74.26 0.22 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.646 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.4 120.79 8.8 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.863 2.375 . . . . 0.0 112.376 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.489 HG23 ' NE2' ' A' ' 39' ' ' GLN . 8.9 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.514 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 90.3 Cg_endo . . . . . 0 N--CA 1.463 -0.288 0 N-CA-C 113.02 0.354 . . . . 0.0 113.02 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.557 ' HE3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -142.06 26.32 1.86 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.265 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.486 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 1.1 mpp_? . . . . . 0 C--O 1.234 0.282 0 CA-C-O 120.943 0.402 . . . . 0.0 111.204 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.441 ' HA ' HD23 ' A' ' 25' ' ' LEU . 39.9 t . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.646 0.26 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 44.3 t . . . . . 0 N--CA 1.462 0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.234 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 22' ' ' VAL . 3.7 mm? . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -103.31 101.87 25.42 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 120.752 0.31 . . . . 0.0 110.845 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 57.6 Cg_exo -53.2 -21.08 15.98 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.322 2.682 . . . . 0.0 113.917 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -49.67 -47.56 50.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.606 0.241 . . . . 0.0 111.251 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 26.4 p -78.7 -29.47 45.46 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.495 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.46 -23.74 58.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.524 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -47.62 -36.21 10.52 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.57 ' HA ' HG13 ' A' ' 36' ' ' ILE . 10.1 mp -57.81 -48.5 79.54 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.519 0.2 . . . . 0.0 111.131 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.55 -25.34 25.42 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.97 -36.52 80.2 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.46 -42.48 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.6 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 31.9 pt -102.48 58.98 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 120.987 0.422 . . . . 0.0 111.419 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.96 77.82 0.8 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.762 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.6 ' CE2' ' HB ' ' A' ' 36' ' ' ILE . 16.3 m-85 -93.76 -30.42 14.87 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.32 0.118 . . . . 0.0 111.32 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 66.89 23.1 10.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.915 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 16.1 pt-20 -106.9 -31.12 8.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.67 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.01 -40.12 72.92 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -39.14 -57.6 1.28 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.564 ' HB3' HG22 ' A' ' 49' ' ' VAL . 7.6 ptm180 -55.6 -34.06 64.52 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -59.02 -38.91 80.37 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 29' ' ' CYS . 3.9 p90 -114.15 20.68 15.41 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -139.8 -63.11 0.51 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.776 0.322 . . . . 0.0 110.608 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.595 ' O ' HG13 ' A' ' 49' ' ' VAL . . . 166.73 141.49 3.17 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.113 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 86.4 Cg_exo -47.21 111.84 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.867 2.378 . . . . 0.0 112.734 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 47' ' ' GLY . 27.6 m . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.539 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 CA--C 1.533 0.437 0 N-CA-C 113.499 0.538 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -150.56 32.77 0.63 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.631 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 1.1 mpp_? . . . . . 0 CA--C 1.532 0.256 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 C--O 1.231 0.102 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.461 0.124 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.709 179.379 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.607 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.336 0.112 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -84.59 113.28 48.11 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.796 0.331 . . . . 0.0 111.026 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.15 -16.11 38.11 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.087 2.525 . . . . 0.0 113.633 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -51.58 -53.11 41.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.528 0.204 . . . . 0.0 111.289 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 27.7 p -77.87 -31.71 51.52 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.301 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -62.26 -30.59 71.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.525 0.202 . . . . 0.0 111.161 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.64 -21.52 54.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.565 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.109 HD11 HD11 ' A' ' 36' ' ' ILE . 39.7 tp -53.26 -38.46 63.04 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.206 0.202 . . . . 0.0 111.496 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.617 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -57.66 -21.44 40.0 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -51.31 -45.47 62.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 -17.63 8.31 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.109 HD11 HD11 ' A' ' 32' ' ' LEU . 20.0 pt -142.04 -55.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 118.529 0.604 . . . . 0.0 112.614 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 62.1 60.72 7.55 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.451 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.56 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 8.0 m-85 -110.93 13.81 22.11 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.704 0.252 . . . . 0.0 111.664 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 58.18 23.28 10.07 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.686 0.279 . . . . 0.0 111.677 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.881 ' HG2' HD21 ' A' ' 32' ' ' LEU . 12.5 pt-20 -84.61 -11.91 55.05 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.207 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.5 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . . . -77.13 -20.1 56.03 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.599 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.632 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 7.0 t80 -61.42 -46.33 90.58 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.319 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 16.7 ptm180 -65.96 -22.31 66.47 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.5 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 99.3 mtt180 -57.4 -34.71 69.16 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.411 0.148 . . . . 0.0 111.226 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.632 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 3.5 p90 -115.17 22.7 13.1 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -138.47 -68.03 0.46 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.785 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.92 -82.78 0.24 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.71 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.43 79.68 3.16 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.931 2.42 . . . . 0.0 112.631 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.749 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo . . . . . 0 C--O 1.233 0.258 0 CA-C-O 120.852 0.271 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -138.89 25.69 2.52 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.552 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.434 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 10.2 mpt_? . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.621 0.248 . . . . 0.0 111.641 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.57 0.224 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 CA--C 1.529 0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.922 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.599 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.1 tm? . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.593 0.235 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . 9.1 p30 -101.64 93.3 3.37 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.957 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 10.4 Cg_endo -53.49 106.95 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.011 2.474 . . . . 0.0 112.921 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 60.6 t0 -159.56 -57.88 0.06 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.138 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 28.7 p -71.58 -44.89 63.67 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -74.53 -37.76 62.97 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.19 -22.2 66.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.021 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.6 HD11 HD11 ' A' ' 36' ' ' ILE . 36.8 tp -55.44 -27.69 49.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.348 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.609 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . . . -52.64 -22.85 5.56 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -42.75 -47.11 5.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.514 0.325 . . . . 0.0 111.692 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.57 -18.0 5.82 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.6 HD11 HD11 ' A' ' 32' ' ' LEU . 16.4 pt -143.79 -56.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.476 0.546 . . . . 0.0 112.476 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 33' ' ' ALA . . . 57.4 71.45 0.74 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.478 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.479 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 10.9 m-85 -117.72 -90.89 0.56 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.8 0.3 . . . . 0.0 111.018 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.41 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 5.2 pt20 -174.79 40.39 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.798 0.333 . . . . 0.0 111.088 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.64 -38.88 5.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.625 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 29' ' ' CYS . . . -56.42 -55.35 34.74 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.353 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.497 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 16.7 t80 -47.92 -41.62 25.12 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.767 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 77.7 mtp180 -60.92 -36.22 78.73 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -58.77 -36.46 74.42 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.497 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 1.9 p90 -114.83 18.3 16.58 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -142.79 -62.82 0.42 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.651 0.262 . . . . 0.0 110.802 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.16 -73.77 0.41 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.2 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.86 112.33 3.37 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.644 2.23 . . . . 0.0 112.053 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.437 ' HB ' ' HD2' ' A' ' 43' ' ' ARG . 12.7 p . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.498 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 CA--C 1.53 0.301 0 CA-C-O 121.032 0.347 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.592 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -111.6 -11.43 14.04 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.426 -179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.592 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 51.1 ttp180 . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 120.932 0.396 . . . . 0.0 111.112 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.553 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 96.3 m . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.35 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.544 ' N ' HD22 ' A' ' 25' ' ' LEU . 2.8 mm? . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.365 0.126 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -103.85 108.45 59.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.867 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 31.4 Cg_exo -60.24 -12.78 21.17 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.109 2.54 . . . . 0.0 113.883 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -47.41 -57.54 5.2 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.484 0.183 . . . . 0.0 111.115 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.473 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 21.3 p -89.4 -24.92 21.8 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.512 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 8.2 t70 -67.36 -15.45 63.69 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.235 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -47.22 -30.41 2.97 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.106 HD11 HD11 ' A' ' 36' ' ' ILE . 24.9 tp -56.51 -41.51 76.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.543 0.211 . . . . 0.0 111.247 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.671 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -64.5 -14.5 57.56 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -69.07 -47.28 65.68 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.442 ' HE1' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -106.31 -17.47 14.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -178.486 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.106 HD11 HD11 ' A' ' 32' ' ' LEU . 24.2 pt -141.73 -54.99 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.671 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 61.66 72.88 0.57 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.249 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.539 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 8.8 m-85 -118.84 25.32 10.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 48.31 46.8 20.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 111.222 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.567 ' CG ' HD21 ' A' ' 32' ' ' LEU . 11.5 pt-20 -134.29 14.71 3.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.063 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.612 ' HB2' ' CB ' ' A' ' 32' ' ' LEU . . . -86.14 -59.86 2.17 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.659 0.266 . . . . 0.0 110.802 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.409 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 11.5 t80 -49.69 -24.89 2.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.55 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.448 ' HG2' HG11 ' A' ' 49' ' ' VAL . 76.4 mtp180 -57.16 -57.49 12.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.681 0.277 . . . . 0.0 111.547 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -78.81 -35.27 44.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.473 ' CE2' ' HA ' ' A' ' 29' ' ' CYS . 12.6 m-85 -66.01 -36.34 83.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.09 -67.04 1.03 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.459 0.171 . . . . 0.0 111.235 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.08 -65.22 0.51 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.823 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.63 143.85 82.51 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.775 2.317 . . . . 0.0 112.609 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.548 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . 35.2 m . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.64 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.648 ' C ' HD13 ' A' ' 16' ' ' LEU . 2.8 tm? . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.938 0.399 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CGU . . . . . 0.54 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 17' ' ' CGU . 50.2 Cg_exo -54.0 95.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.646 2.231 . . . . 0.0 112.4 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 17' ' ' CGU . 98.9 mttt -116.01 -30.71 5.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.856 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.06 -2.31 9.76 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.33 -34.67 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.739 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.552 ' HB2' ' HD2' ' A' ' 42' ' ' TYR . 41.8 t -52.25 -39.39 60.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.63 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.4 mm? -74.06 -50.49 19.44 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.283 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' ND2' ' SG ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -79.05 118.49 72.77 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 111.187 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.611 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 33.1 Cg_exo -60.86 -18.68 58.12 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.028 2.485 . . . . 0.0 113.44 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -47.22 -62.28 1.49 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.494 0.188 . . . . 0.0 111.41 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.447 ' SG ' ' ND2' ' A' ' 26' ' ' ASN . 25.8 p -98.29 -14.74 20.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.689 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.611 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 38.9 t70 -59.42 -32.2 69.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.598 0.237 . . . . 0.0 110.808 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.86 -22.9 62.91 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.483 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.864 HD11 HD11 ' A' ' 36' ' ' ILE . 30.4 tp -56.17 -44.98 79.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.157 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.545 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -59.75 -19.18 48.63 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.56 -40.77 89.17 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.48 -19.74 11.05 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.864 HD11 HD11 ' A' ' 32' ' ' LEU . 19.6 pt -146.45 -55.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 118.437 0.562 . . . . 0.0 112.473 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 62.02 72.34 0.66 Allowed Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.176 -0.535 . . . . 0.0 113.254 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -120.0 -73.0 0.66 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.673 0.236 . . . . 0.0 111.613 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' OE1' HG22 ' A' ' 49' ' ' VAL . 22.1 pt20 -179.6 -31.47 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 11.9 pt-20 -38.9 -47.58 1.45 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.539 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -57.52 -46.42 83.83 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 10.4 t80 -64.99 -37.01 86.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.864 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.465 ' HA ' ' H ' ' A' ' 47' ' ' GLY . 76.2 mtp180 -64.7 -23.5 67.27 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.783 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 76.9 mtt-85 -59.03 -36.73 75.47 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.582 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 3.1 p90 -115.4 12.62 16.36 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -138.12 -72.23 0.42 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.599 0.238 . . . . 0.0 110.702 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.465 ' H ' ' HA ' ' A' ' 43' ' ' ARG . . . 129.63 -67.98 0.55 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.715 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.81 75.88 2.57 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.156 2.571 . . . . 0.0 112.732 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.5 ' HB ' ' CD2' ' A' ' 16' ' ' LEU . 60.1 t . . . . . 0 C--O 1.247 0.974 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.943 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 tp . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.413 0.149 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CGU . . . . . 0.537 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.67 90.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.781 2.321 . . . . 0.0 112.373 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.537 ' HE3' ' HB2' ' A' ' 17' ' ' CGU . 97.2 mttt -116.44 12.88 15.32 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.338 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.499 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 1.2 mpt_? -80.98 58.23 3.36 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.942 0.401 . . . . 0.0 111.856 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.36 -36.54 8.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.258 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 51.7 t -54.65 -47.51 73.44 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.607 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? -61.66 -50.43 72.54 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.766 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -93.12 109.81 42.13 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.98 -19.9 50.49 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.019 2.479 . . . . 0.0 113.358 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -51.19 -49.55 60.75 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.479 0.181 . . . . 0.0 111.414 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.67 -37.94 55.36 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.352 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -58.45 -30.77 67.2 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.541 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -55.44 -34.75 64.74 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.74 ' CD1' HD11 ' A' ' 36' ' ' ILE . 38.4 tp -54.45 -56.77 15.38 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.626 0.251 . . . . 0.0 110.626 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.24 -12.91 61.92 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.694 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.5 -58.16 3.25 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 -15.8 47.62 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.74 HD11 ' CD1' ' A' ' 32' ' ' LEU . 36.3 pt -143.08 147.8 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.883 0.373 . . . . 0.0 111.548 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.91 75.99 1.73 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.765 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.5 ' CD1' HD12 ' A' ' 36' ' ' ILE . 6.3 m-85 -118.49 -44.77 2.64 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 59.21 56.67 3.76 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.183 0.516 . . . . 0.0 110.409 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 43' ' ' ARG . 11.5 pt-20 -149.24 40.32 0.86 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.017 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 32' ' ' LEU . . . -86.19 -46.81 10.04 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.633 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.53 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 11.5 t80 -50.21 -44.89 53.4 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.019 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.605 ' HB3' HG11 ' A' ' 49' ' ' VAL . 18.1 ptp180 -59.21 -32.98 70.44 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -59.0 -36.79 75.52 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 1.7 p90 -117.74 14.45 14.36 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -139.8 -74.22 0.36 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.404 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . 129.96 -61.34 0.66 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.276 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 47' ' ' GLY . 18.4 Cg_endo -58.28 104.5 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.866 2.377 . . . . 0.0 113.016 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.605 HG11 ' HB3' ' A' ' 43' ' ' ARG . 29.2 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.18 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.572 HD13 ' HB2' ' A' ' 39' ' ' GLN . 57.8 tp . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CGU . . . . . 0.47 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.3 105.14 1.8 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.69 2.26 . . . . 0.0 112.007 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.08 44.88 0.49 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.626 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -90.91 36.07 0.91 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.732 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.5 t -94.54 -38.67 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.32 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.6 t -50.01 -43.67 50.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.538 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.625 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? -64.5 -59.42 4.34 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.245 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -79.19 117.8 68.94 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 111.408 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.24 -9.98 24.07 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.899 2.399 . . . . 0.0 113.694 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -50.79 -45.16 59.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.555 0.217 . . . . 0.0 111.234 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.3 p -108.11 -38.57 5.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.665 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.46 -49.04 67.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.565 0.221 . . . . 0.0 111.309 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 31' ' ' GLU . 36.9 tt0 -82.29 5.94 18.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.611 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 36' ' ' ILE . 31.3 tp -59.5 -26.32 65.2 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 122.435 -0.166 . . . . 0.0 111.048 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.673 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -58.48 -19.15 34.61 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -46.81 -45.22 19.91 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.438 0.295 . . . . 0.0 111.62 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -16.81 6.03 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 32' ' ' LEU . 20.4 pt -141.08 -54.02 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.673 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 74.34 59.79 3.75 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.002 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' O ' HD23 ' A' ' 32' ' ' LEU . 11.1 m-85 -126.06 178.51 5.73 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.006 0.431 . . . . 0.0 111.207 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.572 ' HB2' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -105.6 13.73 29.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.145 178.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 16.1 pt-20 -72.26 -28.92 63.44 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.219 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.481 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -78.12 -51.72 9.83 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.107 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -43.61 -50.18 7.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.915 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.541 ' HB3' HG22 ' A' ' 49' ' ' VAL . 39.6 ptt180 -58.13 -30.9 66.69 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 66.4 mtt-85 -63.22 -43.1 99.06 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.402 ' CE1' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -108.57 20.69 18.25 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -139.97 -63.87 0.49 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.738 0.304 . . . . 0.0 110.646 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.8 156.67 9.47 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.31 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.43 104.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.028 2.486 . . . . 0.0 112.732 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 43' ' ' ARG . 28.6 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.516 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.776 HD13 HG12 ' A' ' 49' ' ' VAL . 1.1 pp . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 48.6 Cg_exo -56.07 96.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.022 2.481 . . . . 0.0 112.736 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -111.66 68.79 0.67 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.916 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.427 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -89.91 16.18 8.63 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.725 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.4 t -81.15 -44.98 21.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 42' ' ' TYR . 46.9 t -56.68 -28.82 61.55 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.537 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.47 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.3 mm? -70.44 -36.73 74.14 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.777 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -116.2 83.3 12.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.3 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.64 103.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.129 2.553 . . . . 0.0 113.171 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 54.9 m-20 -146.57 -53.48 0.24 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.296 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 26.8 p -68.23 -33.29 74.13 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.904 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.59 -34.81 74.76 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -59.23 -28.12 66.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.39 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.016 HD11 HD11 ' A' ' 36' ' ' ILE . 28.5 tp -59.41 -36.43 75.84 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.063 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.65 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -59.6 -19.26 47.64 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -53.05 -42.5 65.84 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 -16.04 6.89 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.016 HD11 HD11 ' A' ' 32' ' ' LEU . 21.6 pt -140.05 -55.2 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 118.567 0.621 . . . . 0.0 112.577 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.65 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 65.81 70.77 1.02 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.555 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 8.7 m-85 -122.37 16.88 10.58 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 42.48 34.78 0.57 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.839 0.456 . . . . 0.0 111.822 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.617 ' HG2' HD21 ' A' ' 32' ' ' LEU . 11.8 pt-20 -99.92 -25.43 14.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.82 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.545 ' H ' HD22 ' A' ' 32' ' ' LEU . . . -60.87 -35.86 77.7 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.975 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.48 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 6.6 t80 -49.3 -42.66 41.99 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.014 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.552 ' HG2' ' HB ' ' A' ' 49' ' ' VAL . 76.4 mtp180 -65.03 -31.73 73.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.647 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.477 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 98.5 mtt180 -56.51 -36.92 69.74 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.893 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 28' ' ' ASP . 2.5 p90 -114.33 23.75 12.54 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.46 ' HE1' ' CE2' ' A' ' 45' ' ' PHE . 21.7 m-85 -140.25 -62.63 0.5 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.632 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 48' ' ' PRO . . . 112.73 -98.3 0.95 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.617 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HD3' ' HA3' ' A' ' 47' ' ' GLY . 20.9 Cg_exo -65.33 102.17 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.962 2.442 . . . . 0.0 112.084 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.776 HG12 HD13 ' A' ' 16' ' ' LEU . 34.2 t . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.375 -0.822 . . . . 0.0 111.076 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.307 0.099 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.58 82.57 0.54 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.666 2.244 . . . . 0.0 112.06 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -110.28 -14.76 14.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.416 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -82.11 3.69 26.02 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CGU . . . . . 0.64 ' CD2' HG23 ' A' ' 22' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.64 HG23 ' CD2' ' A' ' 21' ' ' CGU . 62.1 t -87.32 -41.45 14.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.6 t -57.3 -28.86 63.42 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.351 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.45 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.6 mm? -63.71 -34.98 79.09 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.678 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -114.36 82.22 7.33 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.016 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.04 87.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.64 2.894 . . . . 0.0 113.699 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 72.2 m-20 -127.7 -58.75 1.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.622 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 31.1 p -75.85 -43.47 45.58 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.062 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -68.59 -38.77 80.92 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.82 -22.98 65.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.965 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.523 ' CG ' HD11 ' A' ' 36' ' ' ILE . 37.2 tp -56.92 -26.35 59.15 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.344 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.633 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . . . -62.27 -13.7 31.04 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.79 -35.82 61.77 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.11 -9.91 3.79 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.542 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 27.6 pt -138.62 -50.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 118.705 0.684 . . . . 0.0 112.805 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 33' ' ' ALA . . . 81.58 58.62 2.51 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.933 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.542 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 6.8 m-85 -117.97 -35.88 3.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.451 ' H ' HD23 ' A' ' 32' ' ' LEU . 0.8 OUTLIER 61.92 28.36 17.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.981 0.419 . . . . 0.0 110.856 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -87.37 -20.6 26.49 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.137 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.84 -28.87 58.48 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.712 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 45' ' ' PHE . 8.6 t80 -43.56 -45.16 6.52 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.522 0.329 . . . . 0.0 111.596 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.451 ' HG2' ' CG2' ' A' ' 49' ' ' VAL . 87.1 mtm180 -56.48 -38.52 71.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.623 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -57.87 -42.06 83.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.39 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 28' ' ' ASP . 2.7 p90 -108.35 17.24 22.37 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.409 ' CE1' ' CD2' ' A' ' 45' ' ' PHE . 28.6 m-85 -142.26 -71.6 0.33 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.483 0.182 . . . . 0.0 110.564 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.61 -72.84 0.39 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.82 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.65 114.1 3.4 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.728 2.285 . . . . 0.0 112.694 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 43' ' ' ARG . 59.4 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.066 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.703 ' O ' HG22 ' A' ' 49' ' ' VAL . 96.9 mt . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 120.306 0.098 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.73 62.46 8.24 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.647 2.232 . . . . 0.0 112.236 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -123.96 35.16 4.89 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.277 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -95.3 21.0 8.49 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.3 t -84.44 -37.5 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.117 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.9 t -50.2 -40.32 46.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.553 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.614 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? -66.44 -55.91 13.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -82.11 115.09 55.5 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.689 0.281 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.95 84.54 1.46 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.778 2.319 . . . . 0.0 112.846 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -156.22 -66.26 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.131 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.8 p -69.02 -43.35 74.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.351 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -70.67 -35.95 73.08 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.465 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -65.49 -31.2 72.15 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.735 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.628 HD11 HD11 ' A' ' 36' ' ' ILE . 34.9 tp -61.14 -31.97 71.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.738 ' HB2' ' HG3' ' A' ' 39' ' ' GLN . . . -84.18 46.63 1.23 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 111.745 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.64 -55.74 1.01 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.534 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.88 -15.75 35.84 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.017 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.628 HD11 HD11 ' A' ' 32' ' ' LEU . 40.3 pt -134.38 -43.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 33' ' ' ALA . . . 81.59 64.16 1.78 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.782 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.46 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -127.67 -49.7 1.38 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.738 ' HG3' ' HB2' ' A' ' 33' ' ' ALA . 83.3 mt-30 65.2 25.91 12.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 111.202 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -76.62 -26.95 55.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.255 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.493 ' HB1' ' HE1' ' A' ' 45' ' ' PHE . . . -56.32 -35.73 67.89 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.542 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -41.89 -50.09 4.48 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.493 0.317 . . . . 0.0 111.557 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -56.64 -38.91 72.8 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -54.51 -42.74 71.14 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' HE1' ' HB1' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -112.74 22.61 14.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -141.41 -64.94 0.44 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.709 0.29 . . . . 0.0 110.708 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.71 -87.8 0.45 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.055 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.72 78.54 3.31 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.859 2.373 . . . . 0.0 112.184 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 16' ' ' LEU . 12.6 p . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.68 -0.676 . . . . 0.0 111.271 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.783 HD13 ' HB ' ' A' ' 49' ' ' VAL . 55.5 tp . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.869 0.366 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CGU . . . . . 0.563 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 17' ' ' CGU . 82.4 Cg_exo -46.1 91.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.804 2.336 . . . . 0.0 112.683 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -70.73 -23.63 62.47 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.583 -179.408 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HA ' ' HB2' ' A' ' 23' ' ' CYS . 68.6 mtt85 -56.61 -26.01 54.47 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CGU . . . . . 0.411 OE21 ' HB2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.3 t -83.52 -38.55 14.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.317 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 62.0 m -51.91 -34.43 41.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.475 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.1 mm? -77.2 -43.95 31.88 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.104 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -101.45 106.22 44.66 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 72.8 Cg_exo -50.5 -24.5 12.52 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.189 2.593 . . . . 0.0 113.629 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -51.54 -49.07 62.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.593 0.235 . . . . 0.0 111.15 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.408 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 44.6 t -84.65 -35.55 22.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.174 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.422 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 10.5 t70 -56.75 -42.36 79.17 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.661 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.6 -35.53 68.35 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.262 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.562 ' CD1' HD11 ' A' ' 36' ' ' ILE . 39.8 tp -58.96 -59.53 5.32 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.545 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.14 -25.01 58.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -52.16 -57.96 8.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.42 -17.0 15.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.57 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 24.3 pt -144.87 120.17 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.942 0.401 . . . . 0.0 111.473 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.18 67.83 3.21 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.94 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.57 ' CE2' ' HB ' ' A' ' 36' ' ' ILE . 12.9 m-85 -124.14 -176.52 3.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.933 0.397 . . . . 0.0 110.933 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -137.24 40.44 2.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.276 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -91.42 -45.54 8.5 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.365 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.536 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -60.33 -42.74 96.27 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.187 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 19' ' ' LYS . 9.0 t80 -44.76 -43.03 8.23 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.496 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.491 ' CZ ' HG11 ' A' ' 49' ' ' VAL . 57.8 mmt-85 -61.55 -37.41 83.67 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.918 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -55.04 -39.5 69.23 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -113.9 20.39 15.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -138.5 -67.54 0.46 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.481 0.181 . . . . 0.0 110.565 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.65 -101.57 1.86 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.63 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.19 138.51 47.35 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.751 2.3 . . . . 0.0 112.372 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.783 ' HB ' HD13 ' A' ' 16' ' ' LEU . 35.6 m . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.561 -0.733 . . . . 0.0 111.571 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.756 HD13 HG21 ' A' ' 49' ' ' VAL . 46.5 tp . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 119.934 -0.079 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CGU . . . . . 0.665 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.665 ' HD2' ' HB3' ' A' ' 17' ' ' CGU . 18.4 Cg_endo -60.42 101.53 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.79 2.327 . . . . 0.0 112.995 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.584 ' HE3' HD12 ' A' ' 16' ' ' LEU . 19.4 ptpt -123.83 24.64 8.3 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.219 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.409 HH22 HD21 ' A' ' 16' ' ' LEU . 10.4 mpt_? -78.42 65.3 3.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.002 0.429 . . . . 0.0 111.558 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t -87.39 -37.65 11.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.311 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.8 t -57.71 -40.14 78.86 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.057 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? -61.12 -54.13 48.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.932 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.474 ' ND2' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -83.38 123.11 77.24 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 111.206 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 24.6 Cg_exo -63.89 -17.84 61.48 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.973 2.449 . . . . 0.0 113.367 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.86 -63.81 0.99 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.545 0.212 . . . . 0.0 111.434 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.675 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 29.2 p -87.9 -29.8 20.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.247 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.532 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 53.1 t0 -51.04 -38.42 51.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 37.5 tt0 -82.76 52.03 2.03 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.041 0.448 . . . . 0.0 110.992 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.822 HD13 ' HB2' ' A' ' 41' ' ' ALA . 52.5 tp -85.95 -37.79 18.66 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.404 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.54 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . . . -57.73 -20.76 36.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.907 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 56.6 t0 -46.64 -46.35 19.76 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.415 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 -19.67 6.78 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 32' ' ' LEU . 13.4 pt -146.78 -56.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 33' ' ' ALA . . . 62.15 57.85 15.25 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.291 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.52 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -109.81 -89.76 0.48 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.019 0.41 . . . . 0.0 111.467 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -172.23 43.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.629 0.252 . . . . 0.0 111.65 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 12.6 pt-20 -114.66 -35.5 4.84 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.822 ' HB2' HD13 ' A' ' 32' ' ' LEU . . . -50.58 -43.35 56.44 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -63.25 -41.38 99.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.029 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -67.47 -26.32 66.32 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.857 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.462 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 99.4 mtt180 -53.63 -34.26 57.92 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CE2' ' HE1' ' A' ' 46' ' ' TYR . 1.5 p90 -123.06 28.94 6.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.526 ' HE1' ' CE2' ' A' ' 45' ' ' PHE . 13.7 m-85 -139.58 -63.64 0.5 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.805 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.413 ' HA3' ' HD3' ' A' ' 48' ' ' PRO . . . 91.99 -104.87 3.22 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.295 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HD3' ' HA3' ' A' ' 47' ' ' GLY . 29.6 Cg_exo -61.7 131.04 33.66 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.724 2.282 . . . . 0.0 112.137 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.756 HG21 HD13 ' A' ' 16' ' ' LEU . 34.8 m . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.569 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.423 HD11 ' NH1' ' A' ' 20' ' ' ARG . 52.7 tp . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.453 0.168 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.87 90.62 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.653 2.236 . . . . 0.0 112.298 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -145.48 30.2 1.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.215 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 1.1 mpt_? -93.67 63.27 3.37 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.919 0.39 . . . . 0.0 111.451 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.5 t -86.02 -39.21 13.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.362 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 53.2 t -55.04 -41.83 71.88 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.386 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.616 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? -61.01 -55.39 33.44 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.073 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.6 p-10 -87.12 112.66 49.25 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 111.298 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 38.9 Cg_exo -61.28 -14.4 34.04 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.162 2.575 . . . . 0.0 113.792 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.15 -47.84 62.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.495 0.188 . . . . 0.0 110.973 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 25.9 p -100.38 -36.26 9.3 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.003 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.515 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 38.7 t70 -56.73 -48.8 76.95 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.729 0.299 . . . . 0.0 110.59 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 83.2 tt0 -94.52 49.38 1.27 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.127 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.71 HD11 HD11 ' A' ' 36' ' ' ILE . 31.8 tp -68.23 -31.74 71.45 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.759 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.561 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -56.89 -20.49 23.47 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.874 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.515 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 10.2 t70 -46.0 -46.57 16.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.468 0.307 . . . . 0.0 111.543 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.38 -19.31 5.96 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.71 HD11 HD11 ' A' ' 32' ' ' LEU . 19.9 pt -144.25 -55.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 118.309 0.504 . . . . 0.0 112.306 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 68.35 56.84 9.2 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.235 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 8.4 m-85 -116.16 -84.39 0.63 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.773 0.286 . . . . 0.0 111.17 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 38' ' ' PHE . 16.4 tt0 170.59 -33.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.289 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -40.56 -44.02 2.0 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.43 -56.6 15.5 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.504 0.192 . . . . 0.0 111.427 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.415 ' O ' ' HB2' ' A' ' 46' ' ' TYR . 4.3 t80 -48.18 -46.69 35.08 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.596 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.408 HH21 HG21 ' A' ' 49' ' ' VAL . 99.0 mtt180 -58.97 -36.2 74.45 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -52.29 -42.35 63.68 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -118.44 25.34 10.35 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 24.9 m-85 -138.68 -72.67 0.4 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.457 0.17 . . . . 0.0 110.668 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.69 -74.26 0.22 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.646 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.4 120.79 8.8 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.863 2.375 . . . . 0.0 112.376 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.408 HG21 HH21 ' A' ' 43' ' ' ARG . 8.9 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.514 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.574 HD21 ' O ' ' A' ' 39' ' ' GLN . 67.0 tp . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.452 0.168 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 90.3 Cg_endo -83.43 124.8 3.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.814 2.343 . . . . 0.0 113.02 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.557 ' HE3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -142.06 26.32 1.86 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.265 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.486 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 1.1 mpp_? -84.77 55.95 3.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.943 0.402 . . . . 0.0 111.204 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CGU . . . . . 0.437 OE21 ' HA ' ' A' ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.441 ' HA ' HD23 ' A' ' 25' ' ' LEU . 39.9 t -79.67 -32.37 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.384 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 44.3 t -51.05 -46.87 61.79 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.234 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 22' ' ' VAL . 3.7 mm? -63.82 -39.91 95.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.521 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -103.31 101.87 25.42 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 120.752 0.31 . . . . 0.0 110.845 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 57.6 Cg_exo -53.2 -21.08 15.98 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.322 2.682 . . . . 0.0 113.917 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -49.67 -47.56 50.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.606 0.241 . . . . 0.0 111.251 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 26.4 p -78.7 -29.47 45.46 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.495 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.46 -23.74 58.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.524 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -47.62 -36.21 10.52 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.57 ' HA ' HG13 ' A' ' 36' ' ' ILE . 10.1 mp -57.81 -48.5 79.54 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.519 0.2 . . . . 0.0 111.131 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.55 -25.34 25.42 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.97 -36.52 80.2 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.46 -42.48 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.6 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 31.9 pt -102.48 58.98 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 120.987 0.422 . . . . 0.0 111.419 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.96 77.82 0.8 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.762 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.6 ' CE2' ' HB ' ' A' ' 36' ' ' ILE . 16.3 m-85 -93.76 -30.42 14.87 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.32 0.118 . . . . 0.0 111.32 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.574 ' O ' HD21 ' A' ' 16' ' ' LEU . 81.3 mt-30 66.89 23.1 10.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.915 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 16.1 pt-20 -106.9 -31.12 8.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.67 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.01 -40.12 72.92 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -39.14 -57.6 1.28 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.564 ' HB3' HG22 ' A' ' 49' ' ' VAL . 7.6 ptm180 -55.6 -34.06 64.52 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -59.02 -38.91 80.37 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 29' ' ' CYS . 3.9 p90 -114.15 20.68 15.41 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -139.8 -63.11 0.51 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.776 0.322 . . . . 0.0 110.608 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.595 ' O ' HG13 ' A' ' 49' ' ' VAL . . . 166.73 141.49 3.17 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.113 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 86.4 Cg_exo -47.21 111.84 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.867 2.378 . . . . 0.0 112.734 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 47' ' ' GLY . 27.6 m . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.539 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.632 ' HA ' HG11 ' A' ' 49' ' ' VAL . 58.1 tp . . . . . 0 N--CA 1.463 0.212 0 N-CA-C 110.925 -0.028 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CGU . . . . . 0.617 ' CD2' ' C ' ' A' ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 17' ' ' CGU . 94.0 Cg_endo -89.01 84.4 0.58 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.967 2.445 . . . . 0.0 113.499 -178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HB2' OE22 ' A' ' 17' ' ' CGU . 27.6 tptp -150.56 32.77 0.63 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.631 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 1.1 mpp_? -90.04 7.04 39.67 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CGU . . . . . 0.584 OE22 HG23 ' A' ' 22' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.584 HG23 OE22 ' A' ' 21' ' ' CGU . 59.4 t -76.57 -48.0 27.86 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.9 t -56.05 -44.62 79.01 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.709 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.607 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? -68.14 -54.27 19.22 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -84.59 113.28 48.11 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.796 0.331 . . . . 0.0 111.026 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.15 -16.11 38.11 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.087 2.525 . . . . 0.0 113.633 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -51.58 -53.11 41.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.528 0.204 . . . . 0.0 111.289 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 27.7 p -77.87 -31.71 51.52 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.301 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -62.26 -30.59 71.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.525 0.202 . . . . 0.0 111.161 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.64 -21.52 54.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.565 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.109 HD11 HD11 ' A' ' 36' ' ' ILE . 39.7 tp -53.26 -38.46 63.04 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.206 0.202 . . . . 0.0 111.496 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.617 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -57.66 -21.44 40.0 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -51.31 -45.47 62.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 -17.63 8.31 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.109 HD11 HD11 ' A' ' 32' ' ' LEU . 20.0 pt -142.04 -55.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 118.529 0.604 . . . . 0.0 112.614 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 62.1 60.72 7.55 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.451 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.56 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 8.0 m-85 -110.93 13.81 22.11 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.704 0.252 . . . . 0.0 111.664 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 58.18 23.28 10.07 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.686 0.279 . . . . 0.0 111.677 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.881 ' HG2' HD21 ' A' ' 32' ' ' LEU . 12.5 pt-20 -84.61 -11.91 55.05 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.207 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.5 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . . . -77.13 -20.1 56.03 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.599 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.632 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 7.0 t80 -61.42 -46.33 90.58 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.319 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 16.7 ptm180 -65.96 -22.31 66.47 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.5 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 99.3 mtt180 -57.4 -34.71 69.16 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.411 0.148 . . . . 0.0 111.226 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.632 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 3.5 p90 -115.17 22.7 13.1 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -138.47 -68.03 0.46 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.785 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.92 -82.78 0.24 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.71 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.43 79.68 3.16 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.931 2.42 . . . . 0.0 112.631 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.632 HG11 ' HA ' ' A' ' 16' ' ' LEU . 48.2 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.749 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.545 ' C ' HD13 ' A' ' 16' ' ' LEU . 3.1 tm? . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.05 105.16 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.706 2.271 . . . . 0.0 112.46 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -138.89 25.69 2.52 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.552 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.434 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 10.2 mpt_? -96.95 33.67 1.86 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.621 0.248 . . . . 0.0 111.641 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.89 -36.85 8.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.701 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.3 t -62.21 -31.14 71.63 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.599 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.1 tm? -64.62 -43.05 94.98 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.423 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . 9.1 p30 -101.64 93.3 3.37 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.957 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 10.4 Cg_endo -53.49 106.95 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.011 2.474 . . . . 0.0 112.921 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 60.6 t0 -159.56 -57.88 0.06 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.138 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 28.7 p -71.58 -44.89 63.67 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -74.53 -37.76 62.97 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.19 -22.2 66.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.021 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.6 HD11 HD11 ' A' ' 36' ' ' ILE . 36.8 tp -55.44 -27.69 49.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.348 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.609 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . . . -52.64 -22.85 5.56 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -42.75 -47.11 5.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.514 0.325 . . . . 0.0 111.692 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.57 -18.0 5.82 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.6 HD11 HD11 ' A' ' 32' ' ' LEU . 16.4 pt -143.79 -56.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.476 0.546 . . . . 0.0 112.476 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 33' ' ' ALA . . . 57.4 71.45 0.74 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.478 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.479 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 10.9 m-85 -117.72 -90.89 0.56 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.8 0.3 . . . . 0.0 111.018 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.473 ' NE2' HG21 ' A' ' 49' ' ' VAL . 18.2 pt20 -174.79 40.39 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.798 0.333 . . . . 0.0 111.088 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.64 -38.88 5.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.625 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 29' ' ' CYS . . . -56.42 -55.35 34.74 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.353 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.497 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 16.7 t80 -47.92 -41.62 25.12 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.767 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.437 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 77.7 mtp180 -60.92 -36.22 78.73 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -58.77 -36.46 74.42 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.497 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 1.9 p90 -114.83 18.3 16.58 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -142.79 -62.82 0.42 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.651 0.262 . . . . 0.0 110.802 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.16 -73.77 0.41 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.2 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.86 112.33 3.37 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.644 2.23 . . . . 0.0 112.053 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.473 HG21 ' NE2' ' A' ' 39' ' ' GLN . 12.7 p . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.498 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.869 HD11 ' HE3' ' A' ' 19' ' ' LYS . 3.4 tm? . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.374 0.13 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CGU . . . . . 0.528 ' O ' HD13 ' A' ' 16' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HD2' ' HG ' ' A' ' 17' ' ' CGU . 40.3 Cg_endo -66.28 85.47 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.558 2.172 . . . . 0.0 111.932 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.869 ' HE3' HD11 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -111.6 -11.43 14.04 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.426 -179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.592 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 51.1 ttp180 -93.26 34.33 1.15 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.932 0.396 . . . . 0.0 111.112 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.3 t -64.72 -42.86 96.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.425 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.553 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 96.3 m -52.67 -35.11 54.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.35 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.544 ' N ' HD22 ' A' ' 25' ' ' LEU . 2.8 mm? -86.02 -48.5 8.61 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.732 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -103.85 108.45 59.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.867 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 31.4 Cg_exo -60.24 -12.78 21.17 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.109 2.54 . . . . 0.0 113.883 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -47.41 -57.54 5.2 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.484 0.183 . . . . 0.0 111.115 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.473 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 21.3 p -89.4 -24.92 21.8 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.512 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 8.2 t70 -67.36 -15.45 63.69 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.235 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -47.22 -30.41 2.97 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.106 HD11 HD11 ' A' ' 36' ' ' ILE . 24.9 tp -56.51 -41.51 76.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.543 0.211 . . . . 0.0 111.247 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.671 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -64.5 -14.5 57.56 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -69.07 -47.28 65.68 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.442 ' HE1' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -106.31 -17.47 14.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -178.486 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.106 HD11 HD11 ' A' ' 32' ' ' LEU . 24.2 pt -141.73 -54.99 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.671 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 61.66 72.88 0.57 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.249 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.539 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 8.8 m-85 -118.84 25.32 10.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 48.31 46.8 20.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 111.222 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.567 ' CG ' HD21 ' A' ' 32' ' ' LEU . 11.5 pt-20 -134.29 14.71 3.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.063 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.612 ' HB2' ' CB ' ' A' ' 32' ' ' LEU . . . -86.14 -59.86 2.17 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.659 0.266 . . . . 0.0 110.802 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.409 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 11.5 t80 -49.69 -24.89 2.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.55 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.448 ' HG2' HG11 ' A' ' 49' ' ' VAL . 76.4 mtp180 -57.16 -57.49 12.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.681 0.277 . . . . 0.0 111.547 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -78.81 -35.27 44.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.473 ' CE2' ' HA ' ' A' ' 29' ' ' CYS . 12.6 m-85 -66.01 -36.34 83.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.09 -67.04 1.03 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.459 0.171 . . . . 0.0 111.235 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.08 -65.22 0.51 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.823 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.63 143.85 82.51 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.775 2.317 . . . . 0.0 112.609 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.548 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . 35.2 m . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.64 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 CA--C 1.531 0.327 0 CA-C-O 120.935 0.306 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HB3' ' OH ' ' A' ' 42' ' ' TYR . 98.9 mttt -116.01 -30.71 5.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.856 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.655 0.264 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.552 ' HB2' ' HD2' ' A' ' 42' ' ' TYR . 41.8 t . . . . . 0 N--CA 1.464 0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.63 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.4 mm? . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.382 0.134 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -79.05 118.49 72.77 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 111.187 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.611 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 33.1 Cg_exo -60.86 -18.68 58.12 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.028 2.485 . . . . 0.0 113.44 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -47.22 -62.28 1.49 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.494 0.188 . . . . 0.0 111.41 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.8 p -98.29 -14.74 20.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.689 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.611 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 38.9 t70 -59.42 -32.2 69.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.598 0.237 . . . . 0.0 110.808 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.86 -22.9 62.91 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.483 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.864 HD11 HD11 ' A' ' 36' ' ' ILE . 30.4 tp -56.17 -44.98 79.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.157 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.545 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -59.75 -19.18 48.63 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.56 -40.77 89.17 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.546 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -114.48 -19.74 11.05 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.864 HD11 HD11 ' A' ' 32' ' ' LEU . 19.6 pt -146.45 -55.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 118.437 0.562 . . . . 0.0 112.473 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 62.02 72.34 0.66 Allowed Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.176 -0.535 . . . . 0.0 113.254 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -120.0 -73.0 0.66 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.673 0.236 . . . . 0.0 111.613 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.438 ' OE1' HG22 ' A' ' 49' ' ' VAL . 22.1 pt20 -179.6 -31.47 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 11.9 pt-20 -38.9 -47.58 1.45 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.539 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -57.52 -46.42 83.83 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 10.4 t80 -64.99 -37.01 86.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.864 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.465 ' HA ' ' H ' ' A' ' 47' ' ' GLY . 76.2 mtp180 -64.7 -23.5 67.27 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.783 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 76.9 mtt-85 -59.03 -36.73 75.47 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.582 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 3.1 p90 -115.4 12.62 16.36 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -138.12 -72.23 0.42 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.599 0.238 . . . . 0.0 110.702 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.465 ' H ' ' HA ' ' A' ' 43' ' ' ARG . . . 129.63 -67.98 0.55 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.715 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.81 75.88 2.57 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.156 2.571 . . . . 0.0 112.732 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.438 HG22 ' OE1' ' A' ' 39' ' ' GLN . 60.1 t . . . . . 0 C--O 1.247 0.974 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.943 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo . . . . . 0 CA--C 1.53 0.284 0 CA-C-O 120.962 0.318 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.44 12.88 15.32 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.338 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.499 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 1.2 mpt_? . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.942 0.401 . . . . 0.0 111.856 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 C--O 1.232 0.145 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 51.7 t . . . . . 0 N--CA 1.462 0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.607 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.354 0.121 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -93.12 109.81 42.13 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.98 -19.9 50.49 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.019 2.479 . . . . 0.0 113.358 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -51.19 -49.55 60.75 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.479 0.181 . . . . 0.0 111.414 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.67 -37.94 55.36 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.352 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -58.45 -30.77 67.2 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.541 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -55.44 -34.75 64.74 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.74 ' CD1' HD11 ' A' ' 36' ' ' ILE . 38.4 tp -54.45 -56.77 15.38 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.626 0.251 . . . . 0.0 110.626 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.24 -12.91 61.92 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.694 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.5 -58.16 3.25 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.489 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -83.62 -15.8 47.62 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.74 HD11 ' CD1' ' A' ' 32' ' ' LEU . 36.3 pt -143.08 147.8 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.883 0.373 . . . . 0.0 111.548 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.91 75.99 1.73 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.765 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.5 ' CD1' HD12 ' A' ' 36' ' ' ILE . 6.3 m-85 -118.49 -44.77 2.64 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 59.21 56.67 3.76 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.183 0.516 . . . . 0.0 110.409 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 43' ' ' ARG . 11.5 pt-20 -149.24 40.32 0.86 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.017 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 32' ' ' LEU . . . -86.19 -46.81 10.04 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.633 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.53 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 11.5 t80 -50.21 -44.89 53.4 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.019 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.605 ' HB3' HG11 ' A' ' 49' ' ' VAL . 18.1 ptp180 -59.21 -32.98 70.44 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -59.0 -36.79 75.52 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 1.7 p90 -117.74 14.45 14.36 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -139.8 -74.22 0.36 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.404 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . 129.96 -61.34 0.66 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.276 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 47' ' ' GLY . 18.4 Cg_endo -58.28 104.5 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.866 2.377 . . . . 0.0 113.016 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.605 HG11 ' HB3' ' A' ' 43' ' ' ARG . 29.2 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.18 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.233 0.261 0 CA-C-O 120.771 0.238 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.08 44.88 0.49 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.626 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 . . . . . 0 CA--C 1.533 0.292 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.732 179.753 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.5 t . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.538 -179.965 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.625 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.358 0.123 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -79.19 117.8 68.94 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 111.408 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.24 -9.98 24.07 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.899 2.399 . . . . 0.0 113.694 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -50.79 -45.16 59.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.555 0.217 . . . . 0.0 111.234 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.3 p -108.11 -38.57 5.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.665 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.46 -49.04 67.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.565 0.221 . . . . 0.0 111.309 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 31' ' ' GLU . 36.9 tt0 -82.29 5.94 18.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.611 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 36' ' ' ILE . 31.3 tp -59.5 -26.32 65.2 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 122.435 -0.166 . . . . 0.0 111.048 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.673 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -58.48 -19.15 34.61 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -46.81 -45.22 19.91 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.438 0.295 . . . . 0.0 111.62 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.45 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -124.87 -16.81 6.03 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 32' ' ' LEU . 20.4 pt -141.08 -54.02 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.673 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 74.34 59.79 3.75 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.002 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' O ' HD23 ' A' ' 32' ' ' LEU . 11.1 m-85 -126.06 178.51 5.73 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.006 0.431 . . . . 0.0 111.207 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 13.73 29.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.145 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 16.1 pt-20 -72.26 -28.92 63.44 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.219 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.481 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -78.12 -51.72 9.83 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.107 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -43.61 -50.18 7.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.915 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.541 ' HB3' HG22 ' A' ' 49' ' ' VAL . 39.6 ptt180 -58.13 -30.9 66.69 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 66.4 mtt-85 -63.22 -43.1 99.06 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.402 ' CE1' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -108.57 20.69 18.25 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -139.97 -63.87 0.49 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.738 0.304 . . . . 0.0 110.646 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.8 156.67 9.47 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.31 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.43 104.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.028 2.486 . . . . 0.0 112.732 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 43' ' ' ARG . 28.6 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.516 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 48.6 Cg_exo . . . . . 0 C--O 1.233 0.269 0 CA-C-O 120.932 0.305 . . . . 0.0 112.736 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -111.66 68.79 0.67 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.916 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.427 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.725 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.4 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.564 0.221 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 42' ' ' TYR . 46.9 t . . . . . 0 CA--C 1.533 0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.537 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.558 0.218 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -116.2 83.3 12.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.3 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.64 103.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.129 2.553 . . . . 0.0 113.171 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 54.9 m-20 -146.57 -53.48 0.24 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.296 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 26.8 p -68.23 -33.29 74.13 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.904 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.59 -34.81 74.76 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -59.23 -28.12 66.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.39 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.016 HD11 HD11 ' A' ' 36' ' ' ILE . 28.5 tp -59.41 -36.43 75.84 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.063 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.65 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -59.6 -19.26 47.64 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -53.05 -42.5 65.84 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.423 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -123.56 -16.04 6.89 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.016 HD11 HD11 ' A' ' 32' ' ' LEU . 21.6 pt -140.05 -55.2 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 118.567 0.621 . . . . 0.0 112.577 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.65 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 65.81 70.77 1.02 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.555 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 8.7 m-85 -122.37 16.88 10.58 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 42.48 34.78 0.57 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.839 0.456 . . . . 0.0 111.822 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.617 ' HG2' HD21 ' A' ' 32' ' ' LEU . 11.8 pt-20 -99.92 -25.43 14.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.82 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.545 ' H ' HD22 ' A' ' 32' ' ' LEU . . . -60.87 -35.86 77.7 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.975 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.48 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 6.6 t80 -49.3 -42.66 41.99 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.014 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.552 ' HG2' ' HB ' ' A' ' 49' ' ' VAL . 76.4 mtp180 -65.03 -31.73 73.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.647 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.477 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 98.5 mtt180 -56.51 -36.92 69.74 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.893 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 28' ' ' ASP . 2.5 p90 -114.33 23.75 12.54 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.46 ' HE1' ' CE2' ' A' ' 45' ' ' PHE . 21.7 m-85 -140.25 -62.63 0.5 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.632 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 48' ' ' PRO . . . 112.73 -98.3 0.95 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.617 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HD3' ' HA3' ' A' ' 47' ' ' GLY . 20.9 Cg_exo -65.33 102.17 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.962 2.442 . . . . 0.0 112.084 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.552 ' HB ' ' HG2' ' A' ' 43' ' ' ARG . 34.2 t . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.375 -0.822 . . . . 0.0 111.076 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 C--O 1.233 0.256 0 CA-C-O 121.077 0.366 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -110.28 -14.76 14.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.416 ' N ' ' HD3' ' A' ' 20' ' ' ARG . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--O 1.232 0.153 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.6 t . . . . . 0 CA--C 1.532 0.285 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.351 179.496 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.589 0.233 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -114.36 82.22 7.33 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.016 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.04 87.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.64 2.894 . . . . 0.0 113.699 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 72.2 m-20 -127.7 -58.75 1.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.622 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 31.1 p -75.85 -43.47 45.58 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.062 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -68.59 -38.77 80.92 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.82 -22.98 65.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.965 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.523 ' CG ' HD11 ' A' ' 36' ' ' ILE . 37.2 tp -56.92 -26.35 59.15 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.344 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.633 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . . . -62.27 -13.7 31.04 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.79 -35.82 61.77 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.11 -9.91 3.79 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.542 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 27.6 pt -138.62 -50.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 118.705 0.684 . . . . 0.0 112.805 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 33' ' ' ALA . . . 81.58 58.62 2.51 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.933 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.542 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 6.8 m-85 -117.97 -35.88 3.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.451 ' H ' HD23 ' A' ' 32' ' ' LEU . 0.8 OUTLIER 61.92 28.36 17.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.981 0.419 . . . . 0.0 110.856 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -87.37 -20.6 26.49 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.137 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.84 -28.87 58.48 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.712 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 45' ' ' PHE . 8.6 t80 -43.56 -45.16 6.52 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.522 0.329 . . . . 0.0 111.596 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.451 ' HG2' ' CG2' ' A' ' 49' ' ' VAL . 87.1 mtm180 -56.48 -38.52 71.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.623 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -57.87 -42.06 83.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.39 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 28' ' ' ASP . 2.7 p90 -108.35 17.24 22.37 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.409 ' CE1' ' CD2' ' A' ' 45' ' ' PHE . 28.6 m-85 -142.26 -71.6 0.33 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.483 0.182 . . . . 0.0 110.564 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.61 -72.84 0.39 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.82 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.65 114.1 3.4 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.728 2.285 . . . . 0.0 112.694 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 43' ' ' ARG . 59.4 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.066 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 CA--C 1.532 0.402 0 CA-C-O 120.943 0.309 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -123.96 35.16 4.89 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.277 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.406 ' N ' ' HD3' ' A' ' 20' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.273 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.465 0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.553 179.765 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.614 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.444 0.164 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -82.11 115.09 55.5 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.689 0.281 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.95 84.54 1.46 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.778 2.319 . . . . 0.0 112.846 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -156.22 -66.26 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.131 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.8 p -69.02 -43.35 74.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.351 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -70.67 -35.95 73.08 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.465 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -65.49 -31.2 72.15 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.735 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.628 HD11 HD11 ' A' ' 36' ' ' ILE . 34.9 tp -61.14 -31.97 71.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.738 ' HB2' ' HG3' ' A' ' 39' ' ' GLN . . . -84.18 46.63 1.23 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 111.745 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.64 -55.74 1.01 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.534 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.88 -15.75 35.84 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.017 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.628 HD11 HD11 ' A' ' 32' ' ' LEU . 40.3 pt -134.38 -43.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 33' ' ' ALA . . . 81.59 64.16 1.78 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.782 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.46 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -127.67 -49.7 1.38 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.738 ' HG3' ' HB2' ' A' ' 33' ' ' ALA . 83.3 mt-30 65.2 25.91 12.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 111.202 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -76.62 -26.95 55.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.255 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.493 ' HB1' ' HE1' ' A' ' 45' ' ' PHE . . . -56.32 -35.73 67.89 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.542 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -41.89 -50.09 4.48 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.493 0.317 . . . . 0.0 111.557 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -56.64 -38.91 72.8 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -54.51 -42.74 71.14 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' HE1' ' HB1' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -112.74 22.61 14.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -141.41 -64.94 0.44 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.709 0.29 . . . . 0.0 110.708 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.71 -87.8 0.45 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.055 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.72 78.54 3.31 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.859 2.373 . . . . 0.0 112.184 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.68 -0.676 . . . . 0.0 111.271 -179.701 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo . . . . . 0 CA--C 1.53 0.311 0 CA-C-O 121.11 0.379 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -70.73 -23.63 62.47 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.583 -179.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HA ' ' HB2' ' A' ' 23' ' ' CYS . 68.6 mtt85 . . . . . 0 N--CA 1.463 0.19 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.3 t . . . . . 0 C--O 1.232 0.142 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 62.0 m . . . . . 0 N--CA 1.465 0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.475 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.1 mm? . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.372 0.13 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -101.45 106.22 44.66 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 72.8 Cg_exo -50.5 -24.5 12.52 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.189 2.593 . . . . 0.0 113.629 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -51.54 -49.07 62.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.593 0.235 . . . . 0.0 111.15 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.408 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 44.6 t -84.65 -35.55 22.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.174 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.422 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 10.5 t70 -56.75 -42.36 79.17 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.661 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.6 -35.53 68.35 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.262 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.562 ' CD1' HD11 ' A' ' 36' ' ' ILE . 39.8 tp -58.96 -59.53 5.32 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.545 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.14 -25.01 58.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -52.16 -57.96 8.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.544 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -103.42 -17.0 15.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.57 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 24.3 pt -144.87 120.17 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.942 0.401 . . . . 0.0 111.473 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.18 67.83 3.21 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.94 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.57 ' CE2' ' HB ' ' A' ' 36' ' ' ILE . 12.9 m-85 -124.14 -176.52 3.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.933 0.397 . . . . 0.0 110.933 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -137.24 40.44 2.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.276 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -91.42 -45.54 8.5 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.365 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.536 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -60.33 -42.74 96.27 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.187 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 19' ' ' LYS . 9.0 t80 -44.76 -43.03 8.23 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.496 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.491 ' CZ ' HG11 ' A' ' 49' ' ' VAL . 57.8 mmt-85 -61.55 -37.41 83.67 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.918 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -55.04 -39.5 69.23 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -113.9 20.39 15.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -138.5 -67.54 0.46 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.481 0.181 . . . . 0.0 110.565 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.65 -101.57 1.86 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.63 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.19 138.51 47.35 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.751 2.3 . . . . 0.0 112.372 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.491 HG11 ' CZ ' ' A' ' 43' ' ' ARG . 35.6 m . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.561 -0.733 . . . . 0.0 111.571 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 CA--C 1.53 0.322 0 N-CA-C 112.995 0.344 . . . . 0.0 112.995 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -123.83 24.64 8.3 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.219 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.002 0.429 . . . . 0.0 111.558 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.69 0.281 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.8 t . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.057 179.796 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.369 0.128 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.462 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 17.1 p30 -83.38 123.11 77.24 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 111.206 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 24.6 Cg_exo -63.89 -17.84 61.48 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.973 2.449 . . . . 0.0 113.367 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.86 -63.81 0.99 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.545 0.212 . . . . 0.0 111.434 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.675 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 29.2 p -87.9 -29.8 20.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.247 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.532 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 53.1 t0 -51.04 -38.42 51.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 37.5 tt0 -82.76 52.03 2.03 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.041 0.448 . . . . 0.0 110.992 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.822 HD13 ' HB2' ' A' ' 41' ' ' ALA . 52.5 tp -85.95 -37.79 18.66 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.404 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.54 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . . . -57.73 -20.76 36.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.907 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 56.6 t0 -46.64 -46.35 19.76 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.415 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.564 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -121.62 -19.67 6.78 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 32' ' ' LEU . 13.4 pt -146.78 -56.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 33' ' ' ALA . . . 62.15 57.85 15.25 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.291 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.52 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -109.81 -89.76 0.48 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.019 0.41 . . . . 0.0 111.467 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -172.23 43.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.629 0.252 . . . . 0.0 111.65 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 12.6 pt-20 -114.66 -35.5 4.84 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.822 ' HB2' HD13 ' A' ' 32' ' ' LEU . . . -50.58 -43.35 56.44 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -63.25 -41.38 99.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.029 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -67.47 -26.32 66.32 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.857 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.462 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 99.4 mtt180 -53.63 -34.26 57.92 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CE2' ' HE1' ' A' ' 46' ' ' TYR . 1.5 p90 -123.06 28.94 6.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.526 ' HE1' ' CE2' ' A' ' 45' ' ' PHE . 13.7 m-85 -139.58 -63.64 0.5 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.805 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.413 ' HA3' ' HD3' ' A' ' 48' ' ' PRO . . . 91.99 -104.87 3.22 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.295 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HD3' ' HA3' ' A' ' 47' ' ' GLY . 29.6 Cg_exo -61.7 131.04 33.66 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.724 2.282 . . . . 0.0 112.137 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.569 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 CA--C 1.529 0.272 0 CA-C-O 120.993 0.33 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -145.48 30.2 1.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.215 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 1.1 mpt_? . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.919 0.39 . . . . 0.0 111.451 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.709 0.29 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 53.2 t . . . . . 0 CA--C 1.528 0.12 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.386 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.616 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.355 0.122 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.6 p-10 -87.12 112.66 49.25 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 111.298 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 38.9 Cg_exo -61.28 -14.4 34.04 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.162 2.575 . . . . 0.0 113.792 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.15 -47.84 62.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.495 0.188 . . . . 0.0 110.973 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 25.9 p -100.38 -36.26 9.3 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.003 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.515 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 38.7 t70 -56.73 -48.8 76.95 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.729 0.299 . . . . 0.0 110.59 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 83.2 tt0 -94.52 49.38 1.27 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.127 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.71 HD11 HD11 ' A' ' 36' ' ' ILE . 31.8 tp -68.23 -31.74 71.45 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.759 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.561 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -56.89 -20.49 23.47 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.874 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.515 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 10.2 t70 -46.0 -46.57 16.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.468 0.307 . . . . 0.0 111.543 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.514 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -123.38 -19.31 5.96 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.71 HD11 HD11 ' A' ' 32' ' ' LEU . 19.9 pt -144.25 -55.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 118.309 0.504 . . . . 0.0 112.306 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 68.35 56.84 9.2 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.235 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 8.4 m-85 -116.16 -84.39 0.63 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.773 0.286 . . . . 0.0 111.17 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.489 ' NE2' HG23 ' A' ' 49' ' ' VAL . 45.5 tt0 170.59 -33.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.289 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -40.56 -44.02 2.0 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.43 -56.6 15.5 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.504 0.192 . . . . 0.0 111.427 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.415 ' O ' ' HB2' ' A' ' 46' ' ' TYR . 4.3 t80 -48.18 -46.69 35.08 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.596 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.408 HH21 HG21 ' A' ' 49' ' ' VAL . 99.0 mtt180 -58.97 -36.2 74.45 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -52.29 -42.35 63.68 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -118.44 25.34 10.35 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 24.9 m-85 -138.68 -72.67 0.4 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.457 0.17 . . . . 0.0 110.668 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.69 -74.26 0.22 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.646 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.4 120.79 8.8 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.863 2.375 . . . . 0.0 112.376 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.489 HG23 ' NE2' ' A' ' 39' ' ' GLN . 8.9 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.514 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 90.3 Cg_endo . . . . . 0 N--CA 1.463 -0.288 0 N-CA-C 113.02 0.354 . . . . 0.0 113.02 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.557 ' HE3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -142.06 26.32 1.86 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.265 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.486 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 1.1 mpp_? . . . . . 0 C--O 1.234 0.282 0 CA-C-O 120.943 0.402 . . . . 0.0 111.204 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.441 ' HA ' HD23 ' A' ' 25' ' ' LEU . 39.9 t . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.646 0.26 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 44.3 t . . . . . 0 N--CA 1.462 0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.234 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 22' ' ' VAL . 3.7 mm? . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -103.31 101.87 25.42 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 120.752 0.31 . . . . 0.0 110.845 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 57.6 Cg_exo -53.2 -21.08 15.98 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.322 2.682 . . . . 0.0 113.917 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -49.67 -47.56 50.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.606 0.241 . . . . 0.0 111.251 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 26.4 p -78.7 -29.47 45.46 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.495 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.46 -23.74 58.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.524 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -47.62 -36.21 10.52 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.57 ' HA ' HG13 ' A' ' 36' ' ' ILE . 10.1 mp -57.81 -48.5 79.54 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.519 0.2 . . . . 0.0 111.131 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.55 -25.34 25.42 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.97 -36.52 80.2 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.46 -42.48 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.6 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 31.9 pt -102.48 58.98 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 120.987 0.422 . . . . 0.0 111.419 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.96 77.82 0.8 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.762 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.6 ' CE2' ' HB ' ' A' ' 36' ' ' ILE . 16.3 m-85 -93.76 -30.42 14.87 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.32 0.118 . . . . 0.0 111.32 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 66.89 23.1 10.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.915 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 16.1 pt-20 -106.9 -31.12 8.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.67 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.01 -40.12 72.92 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -39.14 -57.6 1.28 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.564 ' HB3' HG22 ' A' ' 49' ' ' VAL . 7.6 ptm180 -55.6 -34.06 64.52 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -59.02 -38.91 80.37 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 29' ' ' CYS . 3.9 p90 -114.15 20.68 15.41 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -139.8 -63.11 0.51 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.776 0.322 . . . . 0.0 110.608 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.595 ' O ' HG13 ' A' ' 49' ' ' VAL . . . 166.73 141.49 3.17 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.113 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 86.4 Cg_exo -47.21 111.84 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.867 2.378 . . . . 0.0 112.734 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 47' ' ' GLY . 27.6 m . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.539 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 CA--C 1.533 0.437 0 N-CA-C 113.499 0.538 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -150.56 32.77 0.63 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.631 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 20' ' ' ARG . 1.1 mpp_? . . . . . 0 CA--C 1.532 0.256 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 C--O 1.231 0.102 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.461 0.124 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.709 179.379 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.607 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.336 0.112 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -84.59 113.28 48.11 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.796 0.331 . . . . 0.0 111.026 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.15 -16.11 38.11 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.087 2.525 . . . . 0.0 113.633 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -51.58 -53.11 41.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.528 0.204 . . . . 0.0 111.289 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 27.7 p -77.87 -31.71 51.52 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.301 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -62.26 -30.59 71.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.525 0.202 . . . . 0.0 111.161 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.64 -21.52 54.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.565 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.109 HD11 HD11 ' A' ' 36' ' ' ILE . 39.7 tp -53.26 -38.46 63.04 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.206 0.202 . . . . 0.0 111.496 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.617 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -57.66 -21.44 40.0 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -51.31 -45.47 62.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.469 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -120.1 -17.63 8.31 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -178.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.109 HD11 HD11 ' A' ' 32' ' ' LEU . 20.0 pt -142.04 -55.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 118.529 0.604 . . . . 0.0 112.614 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 62.1 60.72 7.55 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.451 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.56 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 8.0 m-85 -110.93 13.81 22.11 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.704 0.252 . . . . 0.0 111.664 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 58.18 23.28 10.07 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.686 0.279 . . . . 0.0 111.677 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.881 ' HG2' HD21 ' A' ' 32' ' ' LEU . 12.5 pt-20 -84.61 -11.91 55.05 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.207 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.5 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . . . -77.13 -20.1 56.03 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.599 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.632 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 7.0 t80 -61.42 -46.33 90.58 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.319 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 16.7 ptm180 -65.96 -22.31 66.47 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.5 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 99.3 mtt180 -57.4 -34.71 69.16 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.411 0.148 . . . . 0.0 111.226 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.632 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 3.5 p90 -115.17 22.7 13.1 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -138.47 -68.03 0.46 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.785 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.92 -82.78 0.24 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.71 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.43 79.68 3.16 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.931 2.42 . . . . 0.0 112.631 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.749 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo . . . . . 0 C--O 1.233 0.258 0 CA-C-O 120.852 0.271 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -138.89 25.69 2.52 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.552 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.434 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 10.2 mpt_? . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.621 0.248 . . . . 0.0 111.641 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.57 0.224 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 CA--C 1.529 0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.922 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 25' ' ' LEU . 3.1 tm? . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.593 0.235 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . 9.1 p30 -101.64 93.3 3.37 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.957 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 10.4 Cg_endo -53.49 106.95 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.011 2.474 . . . . 0.0 112.921 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 60.6 t0 -159.56 -57.88 0.06 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.138 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 28.7 p -71.58 -44.89 63.67 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -74.53 -37.76 62.97 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.19 -22.2 66.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.021 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.6 HD11 HD11 ' A' ' 36' ' ' ILE . 36.8 tp -55.44 -27.69 49.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.348 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.609 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . . . -52.64 -22.85 5.56 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -42.75 -47.11 5.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.514 0.325 . . . . 0.0 111.692 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.515 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -124.57 -18.0 5.82 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.6 HD11 HD11 ' A' ' 32' ' ' LEU . 16.4 pt -143.79 -56.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.476 0.546 . . . . 0.0 112.476 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 33' ' ' ALA . . . 57.4 71.45 0.74 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.478 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.479 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 10.9 m-85 -117.72 -90.89 0.56 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.8 0.3 . . . . 0.0 111.018 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.473 ' NE2' HG21 ' A' ' 49' ' ' VAL . 18.2 pt20 -174.79 40.39 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.798 0.333 . . . . 0.0 111.088 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.64 -38.88 5.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.625 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 29' ' ' CYS . . . -56.42 -55.35 34.74 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.353 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.497 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 16.7 t80 -47.92 -41.62 25.12 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.767 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 77.7 mtp180 -60.92 -36.22 78.73 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -58.77 -36.46 74.42 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.497 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 1.9 p90 -114.83 18.3 16.58 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -142.79 -62.82 0.42 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.651 0.262 . . . . 0.0 110.802 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.16 -73.77 0.41 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.2 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.86 112.33 3.37 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.644 2.23 . . . . 0.0 112.053 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.473 HG21 ' NE2' ' A' ' 39' ' ' GLN . 12.7 p . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.498 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 CA--C 1.53 0.301 0 CA-C-O 121.032 0.347 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.592 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -111.6 -11.43 14.04 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.426 -179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.592 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 51.1 ttp180 . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 120.932 0.396 . . . . 0.0 111.112 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.553 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 96.3 m . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.35 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 25' ' ' LEU . 2.8 mm? . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.365 0.126 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -103.85 108.45 59.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.867 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 31.4 Cg_exo -60.24 -12.78 21.17 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.109 2.54 . . . . 0.0 113.883 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -47.41 -57.54 5.2 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.484 0.183 . . . . 0.0 111.115 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.473 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 21.3 p -89.4 -24.92 21.8 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.512 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 8.2 t70 -67.36 -15.45 63.69 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.235 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -47.22 -30.41 2.97 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.106 HD11 HD11 ' A' ' 36' ' ' ILE . 24.9 tp -56.51 -41.51 76.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.543 0.211 . . . . 0.0 111.247 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.671 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -64.5 -14.5 57.56 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -69.07 -47.28 65.68 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.449 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -106.31 -17.47 14.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -178.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.106 HD11 HD11 ' A' ' 32' ' ' LEU . 24.2 pt -141.73 -54.99 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.671 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 61.66 72.88 0.57 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.249 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.539 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 8.8 m-85 -118.84 25.32 10.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 48.31 46.8 20.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 111.222 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.567 ' CG ' HD21 ' A' ' 32' ' ' LEU . 11.5 pt-20 -134.29 14.71 3.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.063 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.612 ' HB2' ' CB ' ' A' ' 32' ' ' LEU . . . -86.14 -59.86 2.17 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.659 0.266 . . . . 0.0 110.802 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.409 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 11.5 t80 -49.69 -24.89 2.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.55 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.448 ' HG2' HG11 ' A' ' 49' ' ' VAL . 76.4 mtp180 -57.16 -57.49 12.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.681 0.277 . . . . 0.0 111.547 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -78.81 -35.27 44.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.473 ' CE2' ' HA ' ' A' ' 29' ' ' CYS . 12.6 m-85 -66.01 -36.34 83.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.09 -67.04 1.03 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.459 0.171 . . . . 0.0 111.235 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.08 -65.22 0.51 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.823 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.63 143.85 82.51 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.775 2.317 . . . . 0.0 112.609 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.548 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . 35.2 m . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.64 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.648 HD13 ' C ' ' A' ' 16' ' ' LEU . 2.8 tm? . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.938 0.399 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . 0.54 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 17' ' ' CGU . 50.2 Cg_exo -54.0 95.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.646 2.231 . . . . 0.0 112.4 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 17' ' ' CGU . 98.9 mttt -116.01 -30.71 5.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.856 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.06 -2.31 9.76 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.33 -34.67 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.739 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.552 ' HB2' ' HD2' ' A' ' 42' ' ' TYR . 41.8 t -52.25 -39.39 60.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.63 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.4 mm? -74.06 -50.49 19.44 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.283 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -79.05 118.49 72.77 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 111.187 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.611 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 33.1 Cg_exo -60.86 -18.68 58.12 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.028 2.485 . . . . 0.0 113.44 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -47.22 -62.28 1.49 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.494 0.188 . . . . 0.0 111.41 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.8 p -98.29 -14.74 20.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.689 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.611 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 38.9 t70 -59.42 -32.2 69.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.598 0.237 . . . . 0.0 110.808 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.86 -22.9 62.91 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.483 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.864 HD11 HD11 ' A' ' 36' ' ' ILE . 30.4 tp -56.17 -44.98 79.84 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.157 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.545 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -59.75 -19.18 48.63 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.56 -40.77 89.17 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.546 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -114.48 -19.74 11.05 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.864 HD11 HD11 ' A' ' 32' ' ' LEU . 19.6 pt -146.45 -55.34 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 118.437 0.562 . . . . 0.0 112.473 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 62.02 72.34 0.66 Allowed Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.176 -0.535 . . . . 0.0 113.254 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -120.0 -73.0 0.66 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.673 0.236 . . . . 0.0 111.613 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' OE1' HG22 ' A' ' 49' ' ' VAL . 22.1 pt20 -179.6 -31.47 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 11.9 pt-20 -38.9 -47.58 1.45 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.539 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -57.52 -46.42 83.83 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 10.4 t80 -64.99 -37.01 86.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.864 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.465 ' HA ' ' H ' ' A' ' 47' ' ' GLY . 76.2 mtp180 -64.7 -23.5 67.27 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.783 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 76.9 mtt-85 -59.03 -36.73 75.47 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.582 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 3.1 p90 -115.4 12.62 16.36 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -138.12 -72.23 0.42 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.599 0.238 . . . . 0.0 110.702 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.465 ' H ' ' HA ' ' A' ' 43' ' ' ARG . . . 129.63 -67.98 0.55 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.715 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.81 75.88 2.57 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.156 2.571 . . . . 0.0 112.732 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.5 ' HB ' ' CD2' ' A' ' 16' ' ' LEU . 60.1 t . . . . . 0 C--O 1.247 0.974 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.943 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 tp . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.413 0.149 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . 0.537 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.67 90.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.781 2.321 . . . . 0.0 112.373 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.537 ' HE3' ' HB2' ' A' ' 17' ' ' CGU . 97.2 mttt -116.44 12.88 15.32 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.338 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.499 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 1.2 mpt_? -80.98 58.23 3.36 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.942 0.401 . . . . 0.0 111.856 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.36 -36.54 8.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.258 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 51.7 t -54.65 -47.51 73.44 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.607 HD13 ' C ' ' A' ' 25' ' ' LEU . 3.0 tm? -61.66 -50.43 72.54 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.766 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -93.12 109.81 42.13 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.98 -19.9 50.49 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.019 2.479 . . . . 0.0 113.358 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -51.19 -49.55 60.75 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.479 0.181 . . . . 0.0 111.414 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 28.6 p -76.67 -37.94 55.36 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.352 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -58.45 -30.77 67.2 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.541 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -55.44 -34.75 64.74 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.74 ' CD1' HD11 ' A' ' 36' ' ' ILE . 38.4 tp -54.45 -56.77 15.38 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.626 0.251 . . . . 0.0 110.626 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.24 -12.91 61.92 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.694 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.5 -58.16 3.25 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.489 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -83.62 -15.8 47.62 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.74 HD11 ' CD1' ' A' ' 32' ' ' LEU . 36.3 pt -143.08 147.8 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.883 0.373 . . . . 0.0 111.548 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.91 75.99 1.73 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.765 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.5 ' CD1' HD12 ' A' ' 36' ' ' ILE . 6.3 m-85 -118.49 -44.77 2.64 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 59.21 56.67 3.76 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.183 0.516 . . . . 0.0 110.409 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 43' ' ' ARG . 11.5 pt-20 -149.24 40.32 0.86 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.017 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 32' ' ' LEU . . . -86.19 -46.81 10.04 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.633 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.53 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 11.5 t80 -50.21 -44.89 53.4 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.019 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.605 ' HB3' HG11 ' A' ' 49' ' ' VAL . 18.1 ptp180 -59.21 -32.98 70.44 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -59.0 -36.79 75.52 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 1.7 p90 -117.74 14.45 14.36 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -139.8 -74.22 0.36 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.404 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . 129.96 -61.34 0.66 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.276 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 47' ' ' GLY . 18.4 Cg_endo -58.28 104.5 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.866 2.377 . . . . 0.0 113.016 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.605 HG11 ' HB3' ' A' ' 43' ' ' ARG . 29.2 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.18 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.572 HD13 ' HB2' ' A' ' 39' ' ' GLN . 57.8 tp . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . 0.47 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.3 105.14 1.8 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.69 2.26 . . . . 0.0 112.007 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.08 44.88 0.49 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.626 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -90.91 36.07 0.91 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.732 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.5 t -94.54 -38.67 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.32 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.6 t -50.01 -43.67 50.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.538 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.625 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? -64.5 -59.42 4.34 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.245 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -79.19 117.8 68.94 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 111.408 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.24 -9.98 24.07 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.899 2.399 . . . . 0.0 113.694 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -50.79 -45.16 59.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.555 0.217 . . . . 0.0 111.234 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.3 p -108.11 -38.57 5.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.665 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.46 -49.04 67.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.565 0.221 . . . . 0.0 111.309 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 31' ' ' GLU . 36.9 tt0 -82.29 5.94 18.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.611 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 36' ' ' ILE . 31.3 tp -59.5 -26.32 65.2 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 122.435 -0.166 . . . . 0.0 111.048 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.673 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -58.48 -19.15 34.61 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -46.81 -45.22 19.91 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.438 0.295 . . . . 0.0 111.62 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.45 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -124.87 -16.81 6.03 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 32' ' ' LEU . 20.4 pt -141.08 -54.02 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.673 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 74.34 59.79 3.75 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.002 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' O ' HD23 ' A' ' 32' ' ' LEU . 11.1 m-85 -126.06 178.51 5.73 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.006 0.431 . . . . 0.0 111.207 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.572 ' HB2' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -105.6 13.73 29.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.145 178.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 16.1 pt-20 -72.26 -28.92 63.44 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.219 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.481 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -78.12 -51.72 9.83 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.107 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -43.61 -50.18 7.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.915 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.541 ' HB3' HG22 ' A' ' 49' ' ' VAL . 39.6 ptt180 -58.13 -30.9 66.69 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 66.4 mtt-85 -63.22 -43.1 99.06 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.402 ' CE1' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -108.57 20.69 18.25 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -139.97 -63.87 0.49 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.738 0.304 . . . . 0.0 110.646 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.8 156.67 9.47 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.31 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -47.43 104.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.028 2.486 . . . . 0.0 112.732 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 43' ' ' ARG . 28.6 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.516 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.776 HD13 HG12 ' A' ' 49' ' ' VAL . 1.1 pp . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 48.6 Cg_exo -56.07 96.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.022 2.481 . . . . 0.0 112.736 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -111.66 68.79 0.67 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.916 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.427 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -89.91 16.18 8.63 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.725 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.4 t -81.15 -44.98 21.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 42' ' ' TYR . 46.9 t -56.68 -28.82 61.55 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.537 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.3 mm? -70.44 -36.73 74.14 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.777 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -116.2 83.3 12.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.3 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.64 103.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.129 2.553 . . . . 0.0 113.171 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 54.9 m-20 -146.57 -53.48 0.24 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.296 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 26.8 p -68.23 -33.29 74.13 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.904 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.59 -34.81 74.76 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.145 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -59.23 -28.12 66.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.39 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.016 HD11 HD11 ' A' ' 36' ' ' ILE . 28.5 tp -59.41 -36.43 75.84 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.063 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.65 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -59.6 -19.26 47.64 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -53.05 -42.5 65.84 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.423 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -123.56 -16.04 6.89 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.016 HD11 HD11 ' A' ' 32' ' ' LEU . 21.6 pt -140.05 -55.2 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 118.567 0.621 . . . . 0.0 112.577 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.65 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 65.81 70.77 1.02 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.555 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 8.7 m-85 -122.37 16.88 10.58 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 42.48 34.78 0.57 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.839 0.456 . . . . 0.0 111.822 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.617 ' HG2' HD21 ' A' ' 32' ' ' LEU . 11.8 pt-20 -99.92 -25.43 14.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.82 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.545 ' H ' HD22 ' A' ' 32' ' ' LEU . . . -60.87 -35.86 77.7 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.975 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.48 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 6.6 t80 -49.3 -42.66 41.99 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.014 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.552 ' HG2' ' HB ' ' A' ' 49' ' ' VAL . 76.4 mtp180 -65.03 -31.73 73.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.647 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.477 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 98.5 mtt180 -56.51 -36.92 69.74 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.893 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 28' ' ' ASP . 2.5 p90 -114.33 23.75 12.54 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.46 ' HE1' ' CE2' ' A' ' 45' ' ' PHE . 21.7 m-85 -140.25 -62.63 0.5 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.632 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 48' ' ' PRO . . . 112.73 -98.3 0.95 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.617 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HD3' ' HA3' ' A' ' 47' ' ' GLY . 20.9 Cg_exo -65.33 102.17 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.962 2.442 . . . . 0.0 112.084 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.776 HG12 HD13 ' A' ' 16' ' ' LEU . 34.2 t . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.375 -0.822 . . . . 0.0 111.076 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.307 0.099 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.58 82.57 0.54 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.666 2.244 . . . . 0.0 112.06 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -110.28 -14.76 14.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.826 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.416 ' N ' ' HD3' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -82.11 3.69 26.02 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . 0.64 ' CD2' HG23 ' A' ' 22' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.64 HG23 ' CD2' ' A' ' 21' ' ' CGU . 62.1 t -87.32 -41.45 14.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.6 t -57.3 -28.86 63.42 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.351 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.6 mm? -63.71 -34.98 79.09 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.678 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -114.36 82.22 7.33 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.016 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.04 87.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.64 2.894 . . . . 0.0 113.699 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 72.2 m-20 -127.7 -58.75 1.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.622 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 31.1 p -75.85 -43.47 45.58 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.062 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -68.59 -38.77 80.92 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.82 -22.98 65.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.965 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.523 ' CG ' HD11 ' A' ' 36' ' ' ILE . 37.2 tp -56.92 -26.35 59.15 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.344 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.633 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . . . -62.27 -13.7 31.04 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.79 -35.82 61.77 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.11 -9.91 3.79 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.542 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 27.6 pt -138.62 -50.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 118.705 0.684 . . . . 0.0 112.805 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 33' ' ' ALA . . . 81.58 58.62 2.51 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.933 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.542 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 6.8 m-85 -117.97 -35.88 3.76 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.451 ' H ' HD23 ' A' ' 32' ' ' LEU . 0.8 OUTLIER 61.92 28.36 17.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.981 0.419 . . . . 0.0 110.856 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -87.37 -20.6 26.49 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.137 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.84 -28.87 58.48 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.712 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 45' ' ' PHE . 8.6 t80 -43.56 -45.16 6.52 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.522 0.329 . . . . 0.0 111.596 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.451 ' HG2' ' CG2' ' A' ' 49' ' ' VAL . 87.1 mtm180 -56.48 -38.52 71.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.623 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -57.87 -42.06 83.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.39 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 28' ' ' ASP . 2.7 p90 -108.35 17.24 22.37 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.409 ' CE1' ' CD2' ' A' ' 45' ' ' PHE . 28.6 m-85 -142.26 -71.6 0.33 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.483 0.182 . . . . 0.0 110.564 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.61 -72.84 0.39 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.82 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.65 114.1 3.4 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.728 2.285 . . . . 0.0 112.694 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 43' ' ' ARG . 59.4 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.066 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.703 ' O ' HG22 ' A' ' 49' ' ' VAL . 96.9 mt . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 120.306 0.098 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.73 62.46 8.24 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.647 2.232 . . . . 0.0 112.236 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -123.96 35.16 4.89 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.277 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.406 ' N ' ' HD3' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -95.3 21.0 8.49 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.3 t -84.44 -37.5 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.117 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.9 t -50.2 -40.32 46.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.553 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.614 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.0 tm? -66.44 -55.91 13.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -82.11 115.09 55.5 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.689 0.281 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.95 84.54 1.46 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.778 2.319 . . . . 0.0 112.846 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -156.22 -66.26 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.131 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.8 p -69.02 -43.35 74.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.351 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -70.67 -35.95 73.08 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.465 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -65.49 -31.2 72.15 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.735 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.628 HD11 HD11 ' A' ' 36' ' ' ILE . 34.9 tp -61.14 -31.97 71.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.821 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.738 ' HB2' ' HG3' ' A' ' 39' ' ' GLN . . . -84.18 46.63 1.23 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 111.745 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.64 -55.74 1.01 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.534 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.88 -15.75 35.84 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.017 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.628 HD11 HD11 ' A' ' 32' ' ' LEU . 40.3 pt -134.38 -43.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 33' ' ' ALA . . . 81.59 64.16 1.78 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.782 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.46 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -127.67 -49.7 1.38 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.738 ' HG3' ' HB2' ' A' ' 33' ' ' ALA . 83.3 mt-30 65.2 25.91 12.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 111.202 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -76.62 -26.95 55.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.255 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.493 ' HB1' ' HE1' ' A' ' 45' ' ' PHE . . . -56.32 -35.73 67.89 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.542 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -41.89 -50.09 4.48 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.493 0.317 . . . . 0.0 111.557 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -56.64 -38.91 72.8 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -54.51 -42.74 71.14 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' HE1' ' HB1' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -112.74 22.61 14.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -141.41 -64.94 0.44 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.709 0.29 . . . . 0.0 110.708 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.71 -87.8 0.45 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.055 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -82.72 78.54 3.31 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.859 2.373 . . . . 0.0 112.184 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 16' ' ' LEU . 12.6 p . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.68 -0.676 . . . . 0.0 111.271 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.783 HD13 ' HB ' ' A' ' 49' ' ' VAL . 55.5 tp . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.869 0.366 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . 0.563 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 17' ' ' CGU . 82.4 Cg_exo -46.1 91.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.804 2.336 . . . . 0.0 112.683 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -70.73 -23.63 62.47 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.583 -179.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HA ' ' HB2' ' A' ' 23' ' ' CYS . 68.6 mtt85 -56.61 -26.01 54.47 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . 0.411 OE21 ' HB2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.3 t -83.52 -38.55 14.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.317 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 62.0 m -51.91 -34.43 41.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.475 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.1 mm? -77.2 -43.95 31.88 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.104 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -101.45 106.22 44.66 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.885 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 72.8 Cg_exo -50.5 -24.5 12.52 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.189 2.593 . . . . 0.0 113.629 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -51.54 -49.07 62.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.593 0.235 . . . . 0.0 111.15 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.408 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 44.6 t -84.65 -35.55 22.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.174 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.422 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 10.5 t70 -56.75 -42.36 79.17 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.661 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.6 -35.53 68.35 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.262 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.562 ' CD1' HD11 ' A' ' 36' ' ' ILE . 39.8 tp -58.96 -59.53 5.32 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.545 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.14 -25.01 58.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -52.16 -57.96 8.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.544 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -103.42 -17.0 15.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.57 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 24.3 pt -144.87 120.17 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.942 0.401 . . . . 0.0 111.473 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.18 67.83 3.21 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.94 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.57 ' CE2' ' HB ' ' A' ' 36' ' ' ILE . 12.9 m-85 -124.14 -176.52 3.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.933 0.397 . . . . 0.0 110.933 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -137.24 40.44 2.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.276 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -91.42 -45.54 8.5 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.365 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.536 ' HB3' HD22 ' A' ' 32' ' ' LEU . . . -60.33 -42.74 96.27 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.187 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 19' ' ' LYS . 9.0 t80 -44.76 -43.03 8.23 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.496 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.491 ' CZ ' HG11 ' A' ' 49' ' ' VAL . 57.8 mmt-85 -61.55 -37.41 83.67 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.918 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -55.04 -39.5 69.23 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -113.9 20.39 15.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -138.5 -67.54 0.46 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.481 0.181 . . . . 0.0 110.565 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.65 -101.57 1.86 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.63 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.19 138.51 47.35 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.751 2.3 . . . . 0.0 112.372 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.783 ' HB ' HD13 ' A' ' 16' ' ' LEU . 35.6 m . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.561 -0.733 . . . . 0.0 111.571 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.756 HD13 HG21 ' A' ' 49' ' ' VAL . 46.5 tp . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 119.934 -0.079 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . 0.665 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.665 ' HD2' ' HB3' ' A' ' 17' ' ' CGU . 18.4 Cg_endo -60.42 101.53 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.79 2.327 . . . . 0.0 112.995 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.584 ' HE3' HD12 ' A' ' 16' ' ' LEU . 19.4 ptpt -123.83 24.64 8.3 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.219 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.409 HH22 HD21 ' A' ' 16' ' ' LEU . 10.4 mpt_? -78.42 65.3 3.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.002 0.429 . . . . 0.0 111.558 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t -87.39 -37.65 11.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.311 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.8 t -57.71 -40.14 78.86 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.057 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.618 HD13 ' C ' ' A' ' 25' ' ' LEU . 3.0 tm? -61.12 -54.13 48.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.932 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.462 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 17.1 p30 -83.38 123.11 77.24 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 111.206 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 24.6 Cg_exo -63.89 -17.84 61.48 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.973 2.449 . . . . 0.0 113.367 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.86 -63.81 0.99 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.545 0.212 . . . . 0.0 111.434 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.675 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 29.2 p -87.9 -29.8 20.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.247 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.532 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 53.1 t0 -51.04 -38.42 51.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 37.5 tt0 -82.76 52.03 2.03 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.041 0.448 . . . . 0.0 110.992 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.822 HD13 ' HB2' ' A' ' 41' ' ' ALA . 52.5 tp -85.95 -37.79 18.66 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.404 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.54 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . . . -57.73 -20.76 36.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.907 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 56.6 t0 -46.64 -46.35 19.76 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.415 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.564 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -121.62 -19.67 6.78 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 32' ' ' LEU . 13.4 pt -146.78 -56.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 33' ' ' ALA . . . 62.15 57.85 15.25 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.291 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.52 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 9.3 m-85 -109.81 -89.76 0.48 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.019 0.41 . . . . 0.0 111.467 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -172.23 43.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.629 0.252 . . . . 0.0 111.65 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 12.6 pt-20 -114.66 -35.5 4.84 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.822 ' HB2' HD13 ' A' ' 32' ' ' LEU . . . -50.58 -43.35 56.44 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -63.25 -41.38 99.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.029 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -67.47 -26.32 66.32 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.857 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.462 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 99.4 mtt180 -53.63 -34.26 57.92 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CE2' ' HE1' ' A' ' 46' ' ' TYR . 1.5 p90 -123.06 28.94 6.95 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.526 ' HE1' ' CE2' ' A' ' 45' ' ' PHE . 13.7 m-85 -139.58 -63.64 0.5 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.805 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.413 ' HA3' ' HD3' ' A' ' 48' ' ' PRO . . . 91.99 -104.87 3.22 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.295 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HD3' ' HA3' ' A' ' 47' ' ' GLY . 29.6 Cg_exo -61.7 131.04 33.66 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.724 2.282 . . . . 0.0 112.137 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.756 HG21 HD13 ' A' ' 16' ' ' LEU . 34.8 m . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.569 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.472 HD12 ' NE2' ' A' ' 39' ' ' GLN . 52.7 tp . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.453 0.168 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.87 90.62 0.43 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.653 2.236 . . . . 0.0 112.298 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -145.48 30.2 1.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.215 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 1.1 mpt_? -93.67 63.27 3.37 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.919 0.39 . . . . 0.0 111.451 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.5 t -86.02 -39.21 13.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.362 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 53.2 t -55.04 -41.83 71.88 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.386 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.616 HD13 ' C ' ' A' ' 25' ' ' LEU . 3.0 tm? -61.01 -55.39 33.44 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.073 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.6 p-10 -87.12 112.66 49.25 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 111.298 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 38.9 Cg_exo -61.28 -14.4 34.04 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.162 2.575 . . . . 0.0 113.792 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.15 -47.84 62.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.495 0.188 . . . . 0.0 110.973 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 25.9 p -100.38 -36.26 9.3 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.003 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.515 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 38.7 t70 -56.73 -48.8 76.95 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.729 0.299 . . . . 0.0 110.59 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 83.2 tt0 -94.52 49.38 1.27 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.127 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.71 HD11 HD11 ' A' ' 36' ' ' ILE . 31.8 tp -68.23 -31.74 71.45 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.759 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.561 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -56.89 -20.49 23.47 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.874 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.515 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 10.2 t70 -46.0 -46.57 16.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.468 0.307 . . . . 0.0 111.543 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.514 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -123.38 -19.31 5.96 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.71 HD11 HD11 ' A' ' 32' ' ' LEU . 19.9 pt -144.25 -55.17 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 118.309 0.504 . . . . 0.0 112.306 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 68.35 56.84 9.2 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.235 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 8.4 m-85 -116.16 -84.39 0.63 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.773 0.286 . . . . 0.0 111.17 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.489 ' NE2' HG23 ' A' ' 49' ' ' VAL . 45.5 tt0 170.59 -33.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.289 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -40.56 -44.02 2.0 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.43 -56.6 15.5 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.504 0.192 . . . . 0.0 111.427 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.415 ' O ' ' HB2' ' A' ' 46' ' ' TYR . 4.3 t80 -48.18 -46.69 35.08 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.596 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.408 HH21 HG21 ' A' ' 49' ' ' VAL . 99.0 mtt180 -58.97 -36.2 74.45 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -52.29 -42.35 63.68 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -118.44 25.34 10.35 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 24.9 m-85 -138.68 -72.67 0.4 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.457 0.17 . . . . 0.0 110.668 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.69 -74.26 0.22 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.646 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.4 120.79 8.8 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.863 2.375 . . . . 0.0 112.376 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.489 HG23 ' NE2' ' A' ' 39' ' ' GLN . 8.9 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.514 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.574 HD21 ' O ' ' A' ' 39' ' ' GLN . 67.0 tp . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.452 0.168 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 90.3 Cg_endo -83.43 124.8 3.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.814 2.343 . . . . 0.0 113.02 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.557 ' HE3' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -142.06 26.32 1.86 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.265 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.486 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 1.1 mpp_? -84.77 55.95 3.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.943 0.402 . . . . 0.0 111.204 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . 0.437 OE21 ' HA ' ' A' ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.441 ' HA ' HD23 ' A' ' 25' ' ' LEU . 39.9 t -79.67 -32.37 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.384 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . 44.3 t -51.05 -46.87 61.79 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.234 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 22' ' ' VAL . 3.7 mm? -63.82 -39.91 95.35 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.521 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -103.31 101.87 25.42 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 120.752 0.31 . . . . 0.0 110.845 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 57.6 Cg_exo -53.2 -21.08 15.98 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.322 2.682 . . . . 0.0 113.917 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -49.67 -47.56 50.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.606 0.241 . . . . 0.0 111.251 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 26.4 p -78.7 -29.47 45.46 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.495 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.46 -23.74 58.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.524 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -47.62 -36.21 10.52 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.57 ' HA ' HG13 ' A' ' 36' ' ' ILE . 10.1 mp -57.81 -48.5 79.54 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.519 0.2 . . . . 0.0 111.131 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.55 -25.34 25.42 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.97 -36.52 80.2 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.46 -42.48 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.6 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 31.9 pt -102.48 58.98 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 120.987 0.422 . . . . 0.0 111.419 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.96 77.82 0.8 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.762 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.6 ' CE2' ' HB ' ' A' ' 36' ' ' ILE . 16.3 m-85 -93.76 -30.42 14.87 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.32 0.118 . . . . 0.0 111.32 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.574 ' O ' HD21 ' A' ' 16' ' ' LEU . 22.8 mt-30 66.89 23.1 10.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.915 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 16.1 pt-20 -106.9 -31.12 8.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.67 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.01 -40.12 72.92 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -39.14 -57.6 1.28 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.564 ' HB3' HG22 ' A' ' 49' ' ' VAL . 7.6 ptm180 -55.6 -34.06 64.52 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -59.02 -38.91 80.37 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 29' ' ' CYS . 3.9 p90 -114.15 20.68 15.41 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -139.8 -63.11 0.51 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.776 0.322 . . . . 0.0 110.608 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.595 ' O ' HG13 ' A' ' 49' ' ' VAL . . . 166.73 141.49 3.17 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.113 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 86.4 Cg_exo -47.21 111.84 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.867 2.378 . . . . 0.0 112.734 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 47' ' ' GLY . 27.6 m . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.539 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.632 ' HA ' HG11 ' A' ' 49' ' ' VAL . 58.1 tp . . . . . 0 N--CA 1.463 0.212 0 N-CA-C 110.925 -0.028 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . 0.617 ' C ' ' CD2' ' A' ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 17' ' ' CGU . 94.0 Cg_endo -89.01 84.4 0.58 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.967 2.445 . . . . 0.0 113.499 -178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HB2' OE22 ' A' ' 17' ' ' CGU . 27.6 tptp -150.56 32.77 0.63 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.631 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 20' ' ' ARG . 1.1 mpp_? -90.04 7.04 39.67 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . 0.584 OE22 HG23 ' A' ' 22' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.584 HG23 OE22 ' A' ' 21' ' ' CGU . 59.4 t -76.57 -48.0 27.86 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.9 t -56.05 -44.62 79.01 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.709 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.607 HD13 ' C ' ' A' ' 25' ' ' LEU . 3.0 tm? -68.14 -54.27 19.22 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -84.59 113.28 48.11 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.796 0.331 . . . . 0.0 111.026 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.15 -16.11 38.11 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.087 2.525 . . . . 0.0 113.633 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -51.58 -53.11 41.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.528 0.204 . . . . 0.0 111.289 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 27.7 p -77.87 -31.71 51.52 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.301 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -62.26 -30.59 71.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.525 0.202 . . . . 0.0 111.161 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.64 -21.52 54.09 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.565 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.109 HD11 HD11 ' A' ' 36' ' ' ILE . 39.7 tp -53.26 -38.46 63.04 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.206 0.202 . . . . 0.0 111.496 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.617 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -57.66 -21.44 40.0 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -51.31 -45.47 62.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.469 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -120.1 -17.63 8.31 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -178.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.109 HD11 HD11 ' A' ' 32' ' ' LEU . 20.0 pt -142.04 -55.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 118.529 0.604 . . . . 0.0 112.614 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 62.1 60.72 7.55 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.451 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.56 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 8.0 m-85 -110.93 13.81 22.11 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.704 0.252 . . . . 0.0 111.664 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 58.18 23.28 10.07 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.686 0.279 . . . . 0.0 111.677 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.881 ' HG2' HD21 ' A' ' 32' ' ' LEU . 12.5 pt-20 -84.61 -11.91 55.05 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.207 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.5 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . . . -77.13 -20.1 56.03 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.599 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.632 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 7.0 t80 -61.42 -46.33 90.58 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.319 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 16.7 ptm180 -65.96 -22.31 66.47 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.5 ' CD ' ' HA ' ' A' ' 41' ' ' ALA . 99.3 mtt180 -57.4 -34.71 69.16 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.411 0.148 . . . . 0.0 111.226 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.632 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 3.5 p90 -115.17 22.7 13.1 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -138.47 -68.03 0.46 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.785 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.92 -82.78 0.24 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.71 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.43 79.68 3.16 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.931 2.42 . . . . 0.0 112.631 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.632 HG11 ' HA ' ' A' ' 16' ' ' LEU . 48.2 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.749 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.545 HD13 ' C ' ' A' ' 16' ' ' LEU . 3.1 tm? . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.05 105.16 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.706 2.271 . . . . 0.0 112.46 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -138.89 25.69 2.52 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.552 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.434 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 10.2 mpt_? -96.95 33.67 1.86 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.621 0.248 . . . . 0.0 111.641 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.89 -36.85 8.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.701 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.3 t -62.21 -31.14 71.63 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 25' ' ' LEU . 3.1 tm? -64.62 -43.05 94.98 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.423 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . 9.1 p30 -101.64 93.3 3.37 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.957 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 10.4 Cg_endo -53.49 106.95 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.011 2.474 . . . . 0.0 112.921 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 60.6 t0 -159.56 -57.88 0.06 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.138 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 28.7 p -71.58 -44.89 63.67 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -74.53 -37.76 62.97 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -63.19 -22.2 66.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.021 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.6 HD11 HD11 ' A' ' 36' ' ' ILE . 36.8 tp -55.44 -27.69 49.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.348 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.609 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . . . -52.64 -22.85 5.56 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -42.75 -47.11 5.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.514 0.325 . . . . 0.0 111.692 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.515 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -124.57 -18.0 5.82 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.6 HD11 HD11 ' A' ' 32' ' ' LEU . 16.4 pt -143.79 -56.93 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.476 0.546 . . . . 0.0 112.476 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 33' ' ' ALA . . . 57.4 71.45 0.74 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.478 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.479 ' CD1' ' HB ' ' A' ' 36' ' ' ILE . 10.9 m-85 -117.72 -90.89 0.56 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.8 0.3 . . . . 0.0 111.018 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.473 ' NE2' HG21 ' A' ' 49' ' ' VAL . 18.2 pt20 -174.79 40.39 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.798 0.333 . . . . 0.0 111.088 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.64 -38.88 5.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.625 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 29' ' ' CYS . . . -56.42 -55.35 34.74 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.353 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.497 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 16.7 t80 -47.92 -41.62 25.12 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.767 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.437 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 77.7 mtp180 -60.92 -36.22 78.73 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -58.77 -36.46 74.42 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.497 ' CE1' ' HA ' ' A' ' 42' ' ' TYR . 1.9 p90 -114.83 18.3 16.58 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -142.79 -62.82 0.42 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.651 0.262 . . . . 0.0 110.802 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.16 -73.77 0.41 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.2 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.86 112.33 3.37 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.644 2.23 . . . . 0.0 112.053 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.473 HG21 ' NE2' ' A' ' 39' ' ' GLN . 12.7 p . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.498 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.869 HD11 ' HE3' ' A' ' 19' ' ' LYS . 3.4 tm? . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.374 0.13 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CGU . . . . . 0.528 ' O ' HD13 ' A' ' 16' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HD2' ' HG ' ' A' ' 17' ' ' CGU . 40.3 Cg_endo -66.28 85.47 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.558 2.172 . . . . 0.0 111.932 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.869 ' HE3' HD11 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -111.6 -11.43 14.04 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.426 -179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.592 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 51.1 ttp180 -93.26 34.33 1.15 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.932 0.396 . . . . 0.0 111.112 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.3 t -64.72 -42.86 96.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.425 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.553 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 96.3 m -52.67 -35.11 54.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.35 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 25' ' ' LEU . 2.8 mm? -86.02 -48.5 8.61 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.732 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -103.85 108.45 59.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.867 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 30' ' ' ASP . 31.4 Cg_exo -60.24 -12.78 21.17 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.109 2.54 . . . . 0.0 113.883 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -47.41 -57.54 5.2 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.484 0.183 . . . . 0.0 111.115 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.473 ' HA ' ' CE2' ' A' ' 45' ' ' PHE . 21.3 p -89.4 -24.92 21.8 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.512 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 27' ' ' PRO . 8.2 t70 -67.36 -15.45 63.69 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.235 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -47.22 -30.41 2.97 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.106 HD11 HD11 ' A' ' 36' ' ' ILE . 24.9 tp -56.51 -41.51 76.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.543 0.211 . . . . 0.0 111.247 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.671 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . . . -64.5 -14.5 57.56 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -69.07 -47.28 65.68 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.449 ' CD2' HG12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -106.31 -17.47 14.28 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -178.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.106 HD11 HD11 ' A' ' 32' ' ' LEU . 24.2 pt -141.73 -54.99 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.671 ' CA ' ' HA ' ' A' ' 33' ' ' ALA . . . 61.66 72.88 0.57 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.249 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.539 ' CE1' ' HB ' ' A' ' 36' ' ' ILE . 8.8 m-85 -118.84 25.32 10.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 48.31 46.8 20.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 111.222 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.567 ' CG ' HD21 ' A' ' 32' ' ' LEU . 11.5 pt-20 -134.29 14.71 3.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.063 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.612 ' HB2' ' CB ' ' A' ' 32' ' ' LEU . . . -86.14 -59.86 2.17 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.659 0.266 . . . . 0.0 110.802 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.409 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 11.5 t80 -49.69 -24.89 2.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.55 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.448 ' HG2' HG11 ' A' ' 49' ' ' VAL . 76.4 mtp180 -57.16 -57.49 12.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.681 0.277 . . . . 0.0 111.547 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -78.81 -35.27 44.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.473 ' CE2' ' HA ' ' A' ' 29' ' ' CYS . 12.6 m-85 -66.01 -36.34 83.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.09 -67.04 1.03 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.459 0.171 . . . . 0.0 111.235 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.08 -65.22 0.51 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.823 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.63 143.85 82.51 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.775 2.317 . . . . 0.0 112.609 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.548 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . 35.2 m . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.64 -179.995 . . . . . . . . 1 1 . 1 stop_ save_